Research ArticleArticle
Updating the OMERACT Filter: Implications for Imaging and Soluble Biomarkers
Maria-Antonietta D’Agostino, Maarten Boers, John Kirwan, Désirée van der Heijde, Mikkel Østergaard, Georg Schett, Robert B. Landewé, Walter P. Maksymowych, Esperanza Naredo, Maxime Dougados, Annamaria Iagnocco, Clifton O. Bingham III, Peter M. Brooks, Dorcas E. Beaton, Frederique Gandjbakhch, Laure Gossec, Francis Guillemin, Sarah E. Hewlett, Margreet Kloppenburg, Lyn March, Philip J. Mease, Ingrid Moller, Lee S. Simon, Jasvinder A. Singh, Vibeke Strand, Richard J. Wakefield, George A. Wells, Peter Tugwell and Philip G. Conaghan
The Journal of Rheumatology March 2014, jrheum.131313; DOI: https://doi.org/10.3899/jrheum.131313
Maria-Antonietta D’Agostino
From Versailles-Saint Quentin En Yvelines University, Department of Rheumatology, Ambroise Paré Hospital, APHP, Boulogne-Billancourt, France; Departments of Epidemiology and Biostatistics, and Rheumatology, VU University Medical Center, Amsterdam, The Netherlands; University of Bristol, Academic Rheumatology Unit, Bristol Royal Infirmary, Bristol, UK; Department of Rheumatology, Leiden University Medical Center, Leiden, The Netherlands; Copenhagen Center for Arthritis Research, Center for Rheumatology and Spine Diseases, Copenhagen University Hospital Glostrup, Copenhagen, Denmark; Department of Internal Medicine 3 and Institute for Clinical Immunology, University of Erlangen-Nuremberg, Erlangen, Germany; Department of Clinical Immunology and Rheumatology, Academic Medical Center, University of Amsterdam and Atrium Medical Center, Amsterdam, The Netherlands; Department of Medicine, University of Alberta, Edmonton, Alberta, Canada; Department of Rheumatology, Hospital General Universitario Gregorio Marañón, Madrid, Spain; Paris-Descartes University, Medicine Faculty, APHP, Cochin Hospital, Rheumatology B, Paris, France; Rheumatology Unit, Sapienza Università di Roma, Rome, Italy; Division of Rheumatology, Johns Hopkins University, Baltimore, Maryland, USA; University of Melbourne, Medicine, Dentistry and Health Sciences, Melbourne, Australia; St. Michael’s Hospital, Mobility Program Clinical Research Unit; Institute for Work and Health; University of Toronto, Department of Health Policy, Management and Evaluation, Department of Rehabilitation Science and Department of Occupational Science and Occupational Therapy, Toronto, Ontario, Canada; Pierre et Marie Curie University (UPMC) — Paris, GRCUPMC 08 (EEMOIS); AP-HP Pitié Salpêtrière Hospital, Department of Rheumatology, Paris; Université de Lorraine, Université Paris Descartes, EA 4360 APEMAC, Nancy and Inserm CIC-EC, CHU de Nancy, Nancy, France; Department of Nursing, University of the West of England, Bristol, UK; Swedish Medical Center and University of Washington, Seattle, Washington, USA; Instituto Poal, Barcelona, Spain; SDG LLC, Cambridge, Massachusetts; Birmingham Veterans Affairs Medical Center and University of Alabama at Birmingham, Birmingham, Alabama; Division of Immunology/Rheumatology, Stanford University School of Medicine, Palo Alto, California, USA; Leeds Institute of Rheumatic and Musculoskeletal Medicine, University of Leeds, and UK National Institute for Health Research, Leeds Musculoskeletal Biomedical Research Unit, Leeds, UK; Department of Epidemiology and Community Medicine, and Department of Medicine, University of Ottawa, Ottawa, Ontario, Canada. M-A. D’Agostino, MD, PhD, Versailles-Saint Quentin En Yvelines University, Department of Rheumatology, Ambroise Paré Hospital, APHP; M. Boers, MD, PhD, Departments of Epidemiology and Biostatistics, and Rheumatology, VU University Medical Center; J.R. Kirwan, MD, University of Bristol, Academic Rheumatology Unit, Bristol Royal Infirmary; D.M. van der Heijde, MD, PhD, Department of Rheumatology, Leiden University Medical Center; M. Østergaard, MD, PhD, DMSc, Copenhagen Center for Arthritis Research, Center for Rheumatology and Spine Diseases, Copenhagen University Hospital Glostrup; G. Schett, MD, Department of Internal Medicine 3 and Institute for Clinical Immunology, University of Erlangen-Nuremberg; R.B. Landewé, MD, PhD, Department of Clinical Immunology and Rheumatology, Academic Medical Center, University of Amsterdam and Atrium Medical Center; W.P. Maksymowych, FRCPC, Department of Medicine, University of Alberta; E. Naredo, MD, Department of Rheumatology, Hospital General Universitario Gregorio Marañón; M. Dougados, MD, Paris-Descartes University, Medicine Faculty, APHP, Cochin Hospital, Rheumatology B; A. Iagnocco, MD, Rheumatology Unit, Sapienza Università di Roma; C.O. Bingham III, MD, Division of Rheumatology, Johns Hopkins University; P. Brooks, MD, FRACP, University of Melbourne, Medicine, Dentistry and Health Sciences; D.E. Beaton, BScOT, PhD, Department of Occupational Sciences and Occupational Therapy, Institute for Health Policy Management and Evaluation, University of Toronto; F. Gandjbakhch, MD; Laure Gossec, MD, PhD, UPMC, GRC-UPMC 08 (EEMOIS); AP-HP Pitié Salpêtrière Hospital, Department of Rheumatology; F. Guillemin, MD, PhD, Université de Lorraine, Université Paris Descartes, EA 4360 APEMAC, Nancy and Inserm CIC-EC, CHU de Nancy; S. Hewlett, PhD, RN, Department of Nursing, University of the West of England; M. Kloppenburg, MD, PhD, Department of Rheumatology, Leiden University Medical Center; P.J. Mease, MD, Swedish Medical Center and University of Washington; I. Moller, MD, Instituto Poal; L.S. Simon, MD, SDG LLC; J.A. Singh, MD, MPH, Birmingham Veterans Affairs Medical Center and University of Alabama at Birmingham; V. Strand, MD, Division of Immunology/Rheumatology, Stanford University School of Medicine; R.J. Wakefield BM, MD, FRCP, Leeds Institute of Rheumatic and Musculoskeletal Medicine, University of Leeds, and NIHR, Leeds Musculoskeletal Biomedical Research Unit; G. Wells, Epidemiology and Community Medicine; P. Tugwell, MD, Department of Medicine, University of Ottawa; P.G. Conaghan, MB, BS, PhD, FRACP, FRCP, Leeds Institute of Rheumatic and Musculoskeletal Medicine, University of Leeds, and NIHR, Leeds Musculoskeletal Biomedical Research Unit. Address correspondence to Prof. D’Agostino, Rheumatology Department, APHP Ambroise Paré Hospital, 9 avenue Charles de Gaulle, 92100 Boulogne-Billancourt, France. E-mail: mariaantonietta.dagostino@apr.aphp.fr
Maarten Boers
From Versailles-Saint Quentin En Yvelines University, Department of Rheumatology, Ambroise Paré Hospital, APHP, Boulogne-Billancourt, France; Departments of Epidemiology and Biostatistics, and Rheumatology, VU University Medical Center, Amsterdam, The Netherlands; University of Bristol, Academic Rheumatology Unit, Bristol Royal Infirmary, Bristol, UK; Department of Rheumatology, Leiden University Medical Center, Leiden, The Netherlands; Copenhagen Center for Arthritis Research, Center for Rheumatology and Spine Diseases, Copenhagen University Hospital Glostrup, Copenhagen, Denmark; Department of Internal Medicine 3 and Institute for Clinical Immunology, University of Erlangen-Nuremberg, Erlangen, Germany; Department of Clinical Immunology and Rheumatology, Academic Medical Center, University of Amsterdam and Atrium Medical Center, Amsterdam, The Netherlands; Department of Medicine, University of Alberta, Edmonton, Alberta, Canada; Department of Rheumatology, Hospital General Universitario Gregorio Marañón, Madrid, Spain; Paris-Descartes University, Medicine Faculty, APHP, Cochin Hospital, Rheumatology B, Paris, France; Rheumatology Unit, Sapienza Università di Roma, Rome, Italy; Division of Rheumatology, Johns Hopkins University, Baltimore, Maryland, USA; University of Melbourne, Medicine, Dentistry and Health Sciences, Melbourne, Australia; St. Michael’s Hospital, Mobility Program Clinical Research Unit; Institute for Work and Health; University of Toronto, Department of Health Policy, Management and Evaluation, Department of Rehabilitation Science and Department of Occupational Science and Occupational Therapy, Toronto, Ontario, Canada; Pierre et Marie Curie University (UPMC) — Paris, GRCUPMC 08 (EEMOIS); AP-HP Pitié Salpêtrière Hospital, Department of Rheumatology, Paris; Université de Lorraine, Université Paris Descartes, EA 4360 APEMAC, Nancy and Inserm CIC-EC, CHU de Nancy, Nancy, France; Department of Nursing, University of the West of England, Bristol, UK; Swedish Medical Center and University of Washington, Seattle, Washington, USA; Instituto Poal, Barcelona, Spain; SDG LLC, Cambridge, Massachusetts; Birmingham Veterans Affairs Medical Center and University of Alabama at Birmingham, Birmingham, Alabama; Division of Immunology/Rheumatology, Stanford University School of Medicine, Palo Alto, California, USA; Leeds Institute of Rheumatic and Musculoskeletal Medicine, University of Leeds, and UK National Institute for Health Research, Leeds Musculoskeletal Biomedical Research Unit, Leeds, UK; Department of Epidemiology and Community Medicine, and Department of Medicine, University of Ottawa, Ottawa, Ontario, Canada. M-A. D’Agostino, MD, PhD, Versailles-Saint Quentin En Yvelines University, Department of Rheumatology, Ambroise Paré Hospital, APHP; M. Boers, MD, PhD, Departments of Epidemiology and Biostatistics, and Rheumatology, VU University Medical Center; J.R. Kirwan, MD, University of Bristol, Academic Rheumatology Unit, Bristol Royal Infirmary; D.M. van der Heijde, MD, PhD, Department of Rheumatology, Leiden University Medical Center; M. Østergaard, MD, PhD, DMSc, Copenhagen Center for Arthritis Research, Center for Rheumatology and Spine Diseases, Copenhagen University Hospital Glostrup; G. Schett, MD, Department of Internal Medicine 3 and Institute for Clinical Immunology, University of Erlangen-Nuremberg; R.B. Landewé, MD, PhD, Department of Clinical Immunology and Rheumatology, Academic Medical Center, University of Amsterdam and Atrium Medical Center; W.P. Maksymowych, FRCPC, Department of Medicine, University of Alberta; E. Naredo, MD, Department of Rheumatology, Hospital General Universitario Gregorio Marañón; M. Dougados, MD, Paris-Descartes University, Medicine Faculty, APHP, Cochin Hospital, Rheumatology B; A. Iagnocco, MD, Rheumatology Unit, Sapienza Università di Roma; C.O. Bingham III, MD, Division of Rheumatology, Johns Hopkins University; P. Brooks, MD, FRACP, University of Melbourne, Medicine, Dentistry and Health Sciences; D.E. Beaton, BScOT, PhD, Department of Occupational Sciences and Occupational Therapy, Institute for Health Policy Management and Evaluation, University of Toronto; F. Gandjbakhch, MD; Laure Gossec, MD, PhD, UPMC, GRC-UPMC 08 (EEMOIS); AP-HP Pitié Salpêtrière Hospital, Department of Rheumatology; F. Guillemin, MD, PhD, Université de Lorraine, Université Paris Descartes, EA 4360 APEMAC, Nancy and Inserm CIC-EC, CHU de Nancy; S. Hewlett, PhD, RN, Department of Nursing, University of the West of England; M. Kloppenburg, MD, PhD, Department of Rheumatology, Leiden University Medical Center; P.J. Mease, MD, Swedish Medical Center and University of Washington; I. Moller, MD, Instituto Poal; L.S. Simon, MD, SDG LLC; J.A. Singh, MD, MPH, Birmingham Veterans Affairs Medical Center and University of Alabama at Birmingham; V. Strand, MD, Division of Immunology/Rheumatology, Stanford University School of Medicine; R.J. Wakefield BM, MD, FRCP, Leeds Institute of Rheumatic and Musculoskeletal Medicine, University of Leeds, and NIHR, Leeds Musculoskeletal Biomedical Research Unit; G. Wells, Epidemiology and Community Medicine; P. Tugwell, MD, Department of Medicine, University of Ottawa; P.G. Conaghan, MB, BS, PhD, FRACP, FRCP, Leeds Institute of Rheumatic and Musculoskeletal Medicine, University of Leeds, and NIHR, Leeds Musculoskeletal Biomedical Research Unit. Address correspondence to Prof. D’Agostino, Rheumatology Department, APHP Ambroise Paré Hospital, 9 avenue Charles de Gaulle, 92100 Boulogne-Billancourt, France. E-mail: mariaantonietta.dagostino@apr.aphp.fr
John Kirwan
From Versailles-Saint Quentin En Yvelines University, Department of Rheumatology, Ambroise Paré Hospital, APHP, Boulogne-Billancourt, France; Departments of Epidemiology and Biostatistics, and Rheumatology, VU University Medical Center, Amsterdam, The Netherlands; University of Bristol, Academic Rheumatology Unit, Bristol Royal Infirmary, Bristol, UK; Department of Rheumatology, Leiden University Medical Center, Leiden, The Netherlands; Copenhagen Center for Arthritis Research, Center for Rheumatology and Spine Diseases, Copenhagen University Hospital Glostrup, Copenhagen, Denmark; Department of Internal Medicine 3 and Institute for Clinical Immunology, University of Erlangen-Nuremberg, Erlangen, Germany; Department of Clinical Immunology and Rheumatology, Academic Medical Center, University of Amsterdam and Atrium Medical Center, Amsterdam, The Netherlands; Department of Medicine, University of Alberta, Edmonton, Alberta, Canada; Department of Rheumatology, Hospital General Universitario Gregorio Marañón, Madrid, Spain; Paris-Descartes University, Medicine Faculty, APHP, Cochin Hospital, Rheumatology B, Paris, France; Rheumatology Unit, Sapienza Università di Roma, Rome, Italy; Division of Rheumatology, Johns Hopkins University, Baltimore, Maryland, USA; University of Melbourne, Medicine, Dentistry and Health Sciences, Melbourne, Australia; St. Michael’s Hospital, Mobility Program Clinical Research Unit; Institute for Work and Health; University of Toronto, Department of Health Policy, Management and Evaluation, Department of Rehabilitation Science and Department of Occupational Science and Occupational Therapy, Toronto, Ontario, Canada; Pierre et Marie Curie University (UPMC) — Paris, GRCUPMC 08 (EEMOIS); AP-HP Pitié Salpêtrière Hospital, Department of Rheumatology, Paris; Université de Lorraine, Université Paris Descartes, EA 4360 APEMAC, Nancy and Inserm CIC-EC, CHU de Nancy, Nancy, France; Department of Nursing, University of the West of England, Bristol, UK; Swedish Medical Center and University of Washington, Seattle, Washington, USA; Instituto Poal, Barcelona, Spain; SDG LLC, Cambridge, Massachusetts; Birmingham Veterans Affairs Medical Center and University of Alabama at Birmingham, Birmingham, Alabama; Division of Immunology/Rheumatology, Stanford University School of Medicine, Palo Alto, California, USA; Leeds Institute of Rheumatic and Musculoskeletal Medicine, University of Leeds, and UK National Institute for Health Research, Leeds Musculoskeletal Biomedical Research Unit, Leeds, UK; Department of Epidemiology and Community Medicine, and Department of Medicine, University of Ottawa, Ottawa, Ontario, Canada. M-A. D’Agostino, MD, PhD, Versailles-Saint Quentin En Yvelines University, Department of Rheumatology, Ambroise Paré Hospital, APHP; M. Boers, MD, PhD, Departments of Epidemiology and Biostatistics, and Rheumatology, VU University Medical Center; J.R. Kirwan, MD, University of Bristol, Academic Rheumatology Unit, Bristol Royal Infirmary; D.M. van der Heijde, MD, PhD, Department of Rheumatology, Leiden University Medical Center; M. Østergaard, MD, PhD, DMSc, Copenhagen Center for Arthritis Research, Center for Rheumatology and Spine Diseases, Copenhagen University Hospital Glostrup; G. Schett, MD, Department of Internal Medicine 3 and Institute for Clinical Immunology, University of Erlangen-Nuremberg; R.B. Landewé, MD, PhD, Department of Clinical Immunology and Rheumatology, Academic Medical Center, University of Amsterdam and Atrium Medical Center; W.P. Maksymowych, FRCPC, Department of Medicine, University of Alberta; E. Naredo, MD, Department of Rheumatology, Hospital General Universitario Gregorio Marañón; M. Dougados, MD, Paris-Descartes University, Medicine Faculty, APHP, Cochin Hospital, Rheumatology B; A. Iagnocco, MD, Rheumatology Unit, Sapienza Università di Roma; C.O. Bingham III, MD, Division of Rheumatology, Johns Hopkins University; P. Brooks, MD, FRACP, University of Melbourne, Medicine, Dentistry and Health Sciences; D.E. Beaton, BScOT, PhD, Department of Occupational Sciences and Occupational Therapy, Institute for Health Policy Management and Evaluation, University of Toronto; F. Gandjbakhch, MD; Laure Gossec, MD, PhD, UPMC, GRC-UPMC 08 (EEMOIS); AP-HP Pitié Salpêtrière Hospital, Department of Rheumatology; F. Guillemin, MD, PhD, Université de Lorraine, Université Paris Descartes, EA 4360 APEMAC, Nancy and Inserm CIC-EC, CHU de Nancy; S. Hewlett, PhD, RN, Department of Nursing, University of the West of England; M. Kloppenburg, MD, PhD, Department of Rheumatology, Leiden University Medical Center; P.J. Mease, MD, Swedish Medical Center and University of Washington; I. Moller, MD, Instituto Poal; L.S. Simon, MD, SDG LLC; J.A. Singh, MD, MPH, Birmingham Veterans Affairs Medical Center and University of Alabama at Birmingham; V. Strand, MD, Division of Immunology/Rheumatology, Stanford University School of Medicine; R.J. Wakefield BM, MD, FRCP, Leeds Institute of Rheumatic and Musculoskeletal Medicine, University of Leeds, and NIHR, Leeds Musculoskeletal Biomedical Research Unit; G. Wells, Epidemiology and Community Medicine; P. Tugwell, MD, Department of Medicine, University of Ottawa; P.G. Conaghan, MB, BS, PhD, FRACP, FRCP, Leeds Institute of Rheumatic and Musculoskeletal Medicine, University of Leeds, and NIHR, Leeds Musculoskeletal Biomedical Research Unit. Address correspondence to Prof. D’Agostino, Rheumatology Department, APHP Ambroise Paré Hospital, 9 avenue Charles de Gaulle, 92100 Boulogne-Billancourt, France. E-mail: mariaantonietta.dagostino@apr.aphp.fr
Désirée van der Heijde
From Versailles-Saint Quentin En Yvelines University, Department of Rheumatology, Ambroise Paré Hospital, APHP, Boulogne-Billancourt, France; Departments of Epidemiology and Biostatistics, and Rheumatology, VU University Medical Center, Amsterdam, The Netherlands; University of Bristol, Academic Rheumatology Unit, Bristol Royal Infirmary, Bristol, UK; Department of Rheumatology, Leiden University Medical Center, Leiden, The Netherlands; Copenhagen Center for Arthritis Research, Center for Rheumatology and Spine Diseases, Copenhagen University Hospital Glostrup, Copenhagen, Denmark; Department of Internal Medicine 3 and Institute for Clinical Immunology, University of Erlangen-Nuremberg, Erlangen, Germany; Department of Clinical Immunology and Rheumatology, Academic Medical Center, University of Amsterdam and Atrium Medical Center, Amsterdam, The Netherlands; Department of Medicine, University of Alberta, Edmonton, Alberta, Canada; Department of Rheumatology, Hospital General Universitario Gregorio Marañón, Madrid, Spain; Paris-Descartes University, Medicine Faculty, APHP, Cochin Hospital, Rheumatology B, Paris, France; Rheumatology Unit, Sapienza Università di Roma, Rome, Italy; Division of Rheumatology, Johns Hopkins University, Baltimore, Maryland, USA; University of Melbourne, Medicine, Dentistry and Health Sciences, Melbourne, Australia; St. Michael’s Hospital, Mobility Program Clinical Research Unit; Institute for Work and Health; University of Toronto, Department of Health Policy, Management and Evaluation, Department of Rehabilitation Science and Department of Occupational Science and Occupational Therapy, Toronto, Ontario, Canada; Pierre et Marie Curie University (UPMC) — Paris, GRCUPMC 08 (EEMOIS); AP-HP Pitié Salpêtrière Hospital, Department of Rheumatology, Paris; Université de Lorraine, Université Paris Descartes, EA 4360 APEMAC, Nancy and Inserm CIC-EC, CHU de Nancy, Nancy, France; Department of Nursing, University of the West of England, Bristol, UK; Swedish Medical Center and University of Washington, Seattle, Washington, USA; Instituto Poal, Barcelona, Spain; SDG LLC, Cambridge, Massachusetts; Birmingham Veterans Affairs Medical Center and University of Alabama at Birmingham, Birmingham, Alabama; Division of Immunology/Rheumatology, Stanford University School of Medicine, Palo Alto, California, USA; Leeds Institute of Rheumatic and Musculoskeletal Medicine, University of Leeds, and UK National Institute for Health Research, Leeds Musculoskeletal Biomedical Research Unit, Leeds, UK; Department of Epidemiology and Community Medicine, and Department of Medicine, University of Ottawa, Ottawa, Ontario, Canada. M-A. D’Agostino, MD, PhD, Versailles-Saint Quentin En Yvelines University, Department of Rheumatology, Ambroise Paré Hospital, APHP; M. Boers, MD, PhD, Departments of Epidemiology and Biostatistics, and Rheumatology, VU University Medical Center; J.R. Kirwan, MD, University of Bristol, Academic Rheumatology Unit, Bristol Royal Infirmary; D.M. van der Heijde, MD, PhD, Department of Rheumatology, Leiden University Medical Center; M. Østergaard, MD, PhD, DMSc, Copenhagen Center for Arthritis Research, Center for Rheumatology and Spine Diseases, Copenhagen University Hospital Glostrup; G. Schett, MD, Department of Internal Medicine 3 and Institute for Clinical Immunology, University of Erlangen-Nuremberg; R.B. Landewé, MD, PhD, Department of Clinical Immunology and Rheumatology, Academic Medical Center, University of Amsterdam and Atrium Medical Center; W.P. Maksymowych, FRCPC, Department of Medicine, University of Alberta; E. Naredo, MD, Department of Rheumatology, Hospital General Universitario Gregorio Marañón; M. Dougados, MD, Paris-Descartes University, Medicine Faculty, APHP, Cochin Hospital, Rheumatology B; A. Iagnocco, MD, Rheumatology Unit, Sapienza Università di Roma; C.O. Bingham III, MD, Division of Rheumatology, Johns Hopkins University; P. Brooks, MD, FRACP, University of Melbourne, Medicine, Dentistry and Health Sciences; D.E. Beaton, BScOT, PhD, Department of Occupational Sciences and Occupational Therapy, Institute for Health Policy Management and Evaluation, University of Toronto; F. Gandjbakhch, MD; Laure Gossec, MD, PhD, UPMC, GRC-UPMC 08 (EEMOIS); AP-HP Pitié Salpêtrière Hospital, Department of Rheumatology; F. Guillemin, MD, PhD, Université de Lorraine, Université Paris Descartes, EA 4360 APEMAC, Nancy and Inserm CIC-EC, CHU de Nancy; S. Hewlett, PhD, RN, Department of Nursing, University of the West of England; M. Kloppenburg, MD, PhD, Department of Rheumatology, Leiden University Medical Center; P.J. Mease, MD, Swedish Medical Center and University of Washington; I. Moller, MD, Instituto Poal; L.S. Simon, MD, SDG LLC; J.A. Singh, MD, MPH, Birmingham Veterans Affairs Medical Center and University of Alabama at Birmingham; V. Strand, MD, Division of Immunology/Rheumatology, Stanford University School of Medicine; R.J. Wakefield BM, MD, FRCP, Leeds Institute of Rheumatic and Musculoskeletal Medicine, University of Leeds, and NIHR, Leeds Musculoskeletal Biomedical Research Unit; G. Wells, Epidemiology and Community Medicine; P. Tugwell, MD, Department of Medicine, University of Ottawa; P.G. Conaghan, MB, BS, PhD, FRACP, FRCP, Leeds Institute of Rheumatic and Musculoskeletal Medicine, University of Leeds, and NIHR, Leeds Musculoskeletal Biomedical Research Unit. Address correspondence to Prof. D’Agostino, Rheumatology Department, APHP Ambroise Paré Hospital, 9 avenue Charles de Gaulle, 92100 Boulogne-Billancourt, France. E-mail: mariaantonietta.dagostino@apr.aphp.fr
Mikkel Østergaard
From Versailles-Saint Quentin En Yvelines University, Department of Rheumatology, Ambroise Paré Hospital, APHP, Boulogne-Billancourt, France; Departments of Epidemiology and Biostatistics, and Rheumatology, VU University Medical Center, Amsterdam, The Netherlands; University of Bristol, Academic Rheumatology Unit, Bristol Royal Infirmary, Bristol, UK; Department of Rheumatology, Leiden University Medical Center, Leiden, The Netherlands; Copenhagen Center for Arthritis Research, Center for Rheumatology and Spine Diseases, Copenhagen University Hospital Glostrup, Copenhagen, Denmark; Department of Internal Medicine 3 and Institute for Clinical Immunology, University of Erlangen-Nuremberg, Erlangen, Germany; Department of Clinical Immunology and Rheumatology, Academic Medical Center, University of Amsterdam and Atrium Medical Center, Amsterdam, The Netherlands; Department of Medicine, University of Alberta, Edmonton, Alberta, Canada; Department of Rheumatology, Hospital General Universitario Gregorio Marañón, Madrid, Spain; Paris-Descartes University, Medicine Faculty, APHP, Cochin Hospital, Rheumatology B, Paris, France; Rheumatology Unit, Sapienza Università di Roma, Rome, Italy; Division of Rheumatology, Johns Hopkins University, Baltimore, Maryland, USA; University of Melbourne, Medicine, Dentistry and Health Sciences, Melbourne, Australia; St. Michael’s Hospital, Mobility Program Clinical Research Unit; Institute for Work and Health; University of Toronto, Department of Health Policy, Management and Evaluation, Department of Rehabilitation Science and Department of Occupational Science and Occupational Therapy, Toronto, Ontario, Canada; Pierre et Marie Curie University (UPMC) — Paris, GRCUPMC 08 (EEMOIS); AP-HP Pitié Salpêtrière Hospital, Department of Rheumatology, Paris; Université de Lorraine, Université Paris Descartes, EA 4360 APEMAC, Nancy and Inserm CIC-EC, CHU de Nancy, Nancy, France; Department of Nursing, University of the West of England, Bristol, UK; Swedish Medical Center and University of Washington, Seattle, Washington, USA; Instituto Poal, Barcelona, Spain; SDG LLC, Cambridge, Massachusetts; Birmingham Veterans Affairs Medical Center and University of Alabama at Birmingham, Birmingham, Alabama; Division of Immunology/Rheumatology, Stanford University School of Medicine, Palo Alto, California, USA; Leeds Institute of Rheumatic and Musculoskeletal Medicine, University of Leeds, and UK National Institute for Health Research, Leeds Musculoskeletal Biomedical Research Unit, Leeds, UK; Department of Epidemiology and Community Medicine, and Department of Medicine, University of Ottawa, Ottawa, Ontario, Canada. M-A. D’Agostino, MD, PhD, Versailles-Saint Quentin En Yvelines University, Department of Rheumatology, Ambroise Paré Hospital, APHP; M. Boers, MD, PhD, Departments of Epidemiology and Biostatistics, and Rheumatology, VU University Medical Center; J.R. Kirwan, MD, University of Bristol, Academic Rheumatology Unit, Bristol Royal Infirmary; D.M. van der Heijde, MD, PhD, Department of Rheumatology, Leiden University Medical Center; M. Østergaard, MD, PhD, DMSc, Copenhagen Center for Arthritis Research, Center for Rheumatology and Spine Diseases, Copenhagen University Hospital Glostrup; G. Schett, MD, Department of Internal Medicine 3 and Institute for Clinical Immunology, University of Erlangen-Nuremberg; R.B. Landewé, MD, PhD, Department of Clinical Immunology and Rheumatology, Academic Medical Center, University of Amsterdam and Atrium Medical Center; W.P. Maksymowych, FRCPC, Department of Medicine, University of Alberta; E. Naredo, MD, Department of Rheumatology, Hospital General Universitario Gregorio Marañón; M. Dougados, MD, Paris-Descartes University, Medicine Faculty, APHP, Cochin Hospital, Rheumatology B; A. Iagnocco, MD, Rheumatology Unit, Sapienza Università di Roma; C.O. Bingham III, MD, Division of Rheumatology, Johns Hopkins University; P. Brooks, MD, FRACP, University of Melbourne, Medicine, Dentistry and Health Sciences; D.E. Beaton, BScOT, PhD, Department of Occupational Sciences and Occupational Therapy, Institute for Health Policy Management and Evaluation, University of Toronto; F. Gandjbakhch, MD; Laure Gossec, MD, PhD, UPMC, GRC-UPMC 08 (EEMOIS); AP-HP Pitié Salpêtrière Hospital, Department of Rheumatology; F. Guillemin, MD, PhD, Université de Lorraine, Université Paris Descartes, EA 4360 APEMAC, Nancy and Inserm CIC-EC, CHU de Nancy; S. Hewlett, PhD, RN, Department of Nursing, University of the West of England; M. Kloppenburg, MD, PhD, Department of Rheumatology, Leiden University Medical Center; P.J. Mease, MD, Swedish Medical Center and University of Washington; I. Moller, MD, Instituto Poal; L.S. Simon, MD, SDG LLC; J.A. Singh, MD, MPH, Birmingham Veterans Affairs Medical Center and University of Alabama at Birmingham; V. Strand, MD, Division of Immunology/Rheumatology, Stanford University School of Medicine; R.J. Wakefield BM, MD, FRCP, Leeds Institute of Rheumatic and Musculoskeletal Medicine, University of Leeds, and NIHR, Leeds Musculoskeletal Biomedical Research Unit; G. Wells, Epidemiology and Community Medicine; P. Tugwell, MD, Department of Medicine, University of Ottawa; P.G. Conaghan, MB, BS, PhD, FRACP, FRCP, Leeds Institute of Rheumatic and Musculoskeletal Medicine, University of Leeds, and NIHR, Leeds Musculoskeletal Biomedical Research Unit. Address correspondence to Prof. D’Agostino, Rheumatology Department, APHP Ambroise Paré Hospital, 9 avenue Charles de Gaulle, 92100 Boulogne-Billancourt, France. E-mail: mariaantonietta.dagostino@apr.aphp.fr
Georg Schett
From Versailles-Saint Quentin En Yvelines University, Department of Rheumatology, Ambroise Paré Hospital, APHP, Boulogne-Billancourt, France; Departments of Epidemiology and Biostatistics, and Rheumatology, VU University Medical Center, Amsterdam, The Netherlands; University of Bristol, Academic Rheumatology Unit, Bristol Royal Infirmary, Bristol, UK; Department of Rheumatology, Leiden University Medical Center, Leiden, The Netherlands; Copenhagen Center for Arthritis Research, Center for Rheumatology and Spine Diseases, Copenhagen University Hospital Glostrup, Copenhagen, Denmark; Department of Internal Medicine 3 and Institute for Clinical Immunology, University of Erlangen-Nuremberg, Erlangen, Germany; Department of Clinical Immunology and Rheumatology, Academic Medical Center, University of Amsterdam and Atrium Medical Center, Amsterdam, The Netherlands; Department of Medicine, University of Alberta, Edmonton, Alberta, Canada; Department of Rheumatology, Hospital General Universitario Gregorio Marañón, Madrid, Spain; Paris-Descartes University, Medicine Faculty, APHP, Cochin Hospital, Rheumatology B, Paris, France; Rheumatology Unit, Sapienza Università di Roma, Rome, Italy; Division of Rheumatology, Johns Hopkins University, Baltimore, Maryland, USA; University of Melbourne, Medicine, Dentistry and Health Sciences, Melbourne, Australia; St. Michael’s Hospital, Mobility Program Clinical Research Unit; Institute for Work and Health; University of Toronto, Department of Health Policy, Management and Evaluation, Department of Rehabilitation Science and Department of Occupational Science and Occupational Therapy, Toronto, Ontario, Canada; Pierre et Marie Curie University (UPMC) — Paris, GRCUPMC 08 (EEMOIS); AP-HP Pitié Salpêtrière Hospital, Department of Rheumatology, Paris; Université de Lorraine, Université Paris Descartes, EA 4360 APEMAC, Nancy and Inserm CIC-EC, CHU de Nancy, Nancy, France; Department of Nursing, University of the West of England, Bristol, UK; Swedish Medical Center and University of Washington, Seattle, Washington, USA; Instituto Poal, Barcelona, Spain; SDG LLC, Cambridge, Massachusetts; Birmingham Veterans Affairs Medical Center and University of Alabama at Birmingham, Birmingham, Alabama; Division of Immunology/Rheumatology, Stanford University School of Medicine, Palo Alto, California, USA; Leeds Institute of Rheumatic and Musculoskeletal Medicine, University of Leeds, and UK National Institute for Health Research, Leeds Musculoskeletal Biomedical Research Unit, Leeds, UK; Department of Epidemiology and Community Medicine, and Department of Medicine, University of Ottawa, Ottawa, Ontario, Canada. M-A. D’Agostino, MD, PhD, Versailles-Saint Quentin En Yvelines University, Department of Rheumatology, Ambroise Paré Hospital, APHP; M. Boers, MD, PhD, Departments of Epidemiology and Biostatistics, and Rheumatology, VU University Medical Center; J.R. Kirwan, MD, University of Bristol, Academic Rheumatology Unit, Bristol Royal Infirmary; D.M. van der Heijde, MD, PhD, Department of Rheumatology, Leiden University Medical Center; M. Østergaard, MD, PhD, DMSc, Copenhagen Center for Arthritis Research, Center for Rheumatology and Spine Diseases, Copenhagen University Hospital Glostrup; G. Schett, MD, Department of Internal Medicine 3 and Institute for Clinical Immunology, University of Erlangen-Nuremberg; R.B. Landewé, MD, PhD, Department of Clinical Immunology and Rheumatology, Academic Medical Center, University of Amsterdam and Atrium Medical Center; W.P. Maksymowych, FRCPC, Department of Medicine, University of Alberta; E. Naredo, MD, Department of Rheumatology, Hospital General Universitario Gregorio Marañón; M. Dougados, MD, Paris-Descartes University, Medicine Faculty, APHP, Cochin Hospital, Rheumatology B; A. Iagnocco, MD, Rheumatology Unit, Sapienza Università di Roma; C.O. Bingham III, MD, Division of Rheumatology, Johns Hopkins University; P. Brooks, MD, FRACP, University of Melbourne, Medicine, Dentistry and Health Sciences; D.E. Beaton, BScOT, PhD, Department of Occupational Sciences and Occupational Therapy, Institute for Health Policy Management and Evaluation, University of Toronto; F. Gandjbakhch, MD; Laure Gossec, MD, PhD, UPMC, GRC-UPMC 08 (EEMOIS); AP-HP Pitié Salpêtrière Hospital, Department of Rheumatology; F. Guillemin, MD, PhD, Université de Lorraine, Université Paris Descartes, EA 4360 APEMAC, Nancy and Inserm CIC-EC, CHU de Nancy; S. Hewlett, PhD, RN, Department of Nursing, University of the West of England; M. Kloppenburg, MD, PhD, Department of Rheumatology, Leiden University Medical Center; P.J. Mease, MD, Swedish Medical Center and University of Washington; I. Moller, MD, Instituto Poal; L.S. Simon, MD, SDG LLC; J.A. Singh, MD, MPH, Birmingham Veterans Affairs Medical Center and University of Alabama at Birmingham; V. Strand, MD, Division of Immunology/Rheumatology, Stanford University School of Medicine; R.J. Wakefield BM, MD, FRCP, Leeds Institute of Rheumatic and Musculoskeletal Medicine, University of Leeds, and NIHR, Leeds Musculoskeletal Biomedical Research Unit; G. Wells, Epidemiology and Community Medicine; P. Tugwell, MD, Department of Medicine, University of Ottawa; P.G. Conaghan, MB, BS, PhD, FRACP, FRCP, Leeds Institute of Rheumatic and Musculoskeletal Medicine, University of Leeds, and NIHR, Leeds Musculoskeletal Biomedical Research Unit. Address correspondence to Prof. D’Agostino, Rheumatology Department, APHP Ambroise Paré Hospital, 9 avenue Charles de Gaulle, 92100 Boulogne-Billancourt, France. E-mail: mariaantonietta.dagostino@apr.aphp.fr
Robert B. Landewé
From Versailles-Saint Quentin En Yvelines University, Department of Rheumatology, Ambroise Paré Hospital, APHP, Boulogne-Billancourt, France; Departments of Epidemiology and Biostatistics, and Rheumatology, VU University Medical Center, Amsterdam, The Netherlands; University of Bristol, Academic Rheumatology Unit, Bristol Royal Infirmary, Bristol, UK; Department of Rheumatology, Leiden University Medical Center, Leiden, The Netherlands; Copenhagen Center for Arthritis Research, Center for Rheumatology and Spine Diseases, Copenhagen University Hospital Glostrup, Copenhagen, Denmark; Department of Internal Medicine 3 and Institute for Clinical Immunology, University of Erlangen-Nuremberg, Erlangen, Germany; Department of Clinical Immunology and Rheumatology, Academic Medical Center, University of Amsterdam and Atrium Medical Center, Amsterdam, The Netherlands; Department of Medicine, University of Alberta, Edmonton, Alberta, Canada; Department of Rheumatology, Hospital General Universitario Gregorio Marañón, Madrid, Spain; Paris-Descartes University, Medicine Faculty, APHP, Cochin Hospital, Rheumatology B, Paris, France; Rheumatology Unit, Sapienza Università di Roma, Rome, Italy; Division of Rheumatology, Johns Hopkins University, Baltimore, Maryland, USA; University of Melbourne, Medicine, Dentistry and Health Sciences, Melbourne, Australia; St. Michael’s Hospital, Mobility Program Clinical Research Unit; Institute for Work and Health; University of Toronto, Department of Health Policy, Management and Evaluation, Department of Rehabilitation Science and Department of Occupational Science and Occupational Therapy, Toronto, Ontario, Canada; Pierre et Marie Curie University (UPMC) — Paris, GRCUPMC 08 (EEMOIS); AP-HP Pitié Salpêtrière Hospital, Department of Rheumatology, Paris; Université de Lorraine, Université Paris Descartes, EA 4360 APEMAC, Nancy and Inserm CIC-EC, CHU de Nancy, Nancy, France; Department of Nursing, University of the West of England, Bristol, UK; Swedish Medical Center and University of Washington, Seattle, Washington, USA; Instituto Poal, Barcelona, Spain; SDG LLC, Cambridge, Massachusetts; Birmingham Veterans Affairs Medical Center and University of Alabama at Birmingham, Birmingham, Alabama; Division of Immunology/Rheumatology, Stanford University School of Medicine, Palo Alto, California, USA; Leeds Institute of Rheumatic and Musculoskeletal Medicine, University of Leeds, and UK National Institute for Health Research, Leeds Musculoskeletal Biomedical Research Unit, Leeds, UK; Department of Epidemiology and Community Medicine, and Department of Medicine, University of Ottawa, Ottawa, Ontario, Canada. M-A. D’Agostino, MD, PhD, Versailles-Saint Quentin En Yvelines University, Department of Rheumatology, Ambroise Paré Hospital, APHP; M. Boers, MD, PhD, Departments of Epidemiology and Biostatistics, and Rheumatology, VU University Medical Center; J.R. Kirwan, MD, University of Bristol, Academic Rheumatology Unit, Bristol Royal Infirmary; D.M. van der Heijde, MD, PhD, Department of Rheumatology, Leiden University Medical Center; M. Østergaard, MD, PhD, DMSc, Copenhagen Center for Arthritis Research, Center for Rheumatology and Spine Diseases, Copenhagen University Hospital Glostrup; G. Schett, MD, Department of Internal Medicine 3 and Institute for Clinical Immunology, University of Erlangen-Nuremberg; R.B. Landewé, MD, PhD, Department of Clinical Immunology and Rheumatology, Academic Medical Center, University of Amsterdam and Atrium Medical Center; W.P. Maksymowych, FRCPC, Department of Medicine, University of Alberta; E. Naredo, MD, Department of Rheumatology, Hospital General Universitario Gregorio Marañón; M. Dougados, MD, Paris-Descartes University, Medicine Faculty, APHP, Cochin Hospital, Rheumatology B; A. Iagnocco, MD, Rheumatology Unit, Sapienza Università di Roma; C.O. Bingham III, MD, Division of Rheumatology, Johns Hopkins University; P. Brooks, MD, FRACP, University of Melbourne, Medicine, Dentistry and Health Sciences; D.E. Beaton, BScOT, PhD, Department of Occupational Sciences and Occupational Therapy, Institute for Health Policy Management and Evaluation, University of Toronto; F. Gandjbakhch, MD; Laure Gossec, MD, PhD, UPMC, GRC-UPMC 08 (EEMOIS); AP-HP Pitié Salpêtrière Hospital, Department of Rheumatology; F. Guillemin, MD, PhD, Université de Lorraine, Université Paris Descartes, EA 4360 APEMAC, Nancy and Inserm CIC-EC, CHU de Nancy; S. Hewlett, PhD, RN, Department of Nursing, University of the West of England; M. Kloppenburg, MD, PhD, Department of Rheumatology, Leiden University Medical Center; P.J. Mease, MD, Swedish Medical Center and University of Washington; I. Moller, MD, Instituto Poal; L.S. Simon, MD, SDG LLC; J.A. Singh, MD, MPH, Birmingham Veterans Affairs Medical Center and University of Alabama at Birmingham; V. Strand, MD, Division of Immunology/Rheumatology, Stanford University School of Medicine; R.J. Wakefield BM, MD, FRCP, Leeds Institute of Rheumatic and Musculoskeletal Medicine, University of Leeds, and NIHR, Leeds Musculoskeletal Biomedical Research Unit; G. Wells, Epidemiology and Community Medicine; P. Tugwell, MD, Department of Medicine, University of Ottawa; P.G. Conaghan, MB, BS, PhD, FRACP, FRCP, Leeds Institute of Rheumatic and Musculoskeletal Medicine, University of Leeds, and NIHR, Leeds Musculoskeletal Biomedical Research Unit. Address correspondence to Prof. D’Agostino, Rheumatology Department, APHP Ambroise Paré Hospital, 9 avenue Charles de Gaulle, 92100 Boulogne-Billancourt, France. E-mail: mariaantonietta.dagostino@apr.aphp.fr
Walter P. Maksymowych
From Versailles-Saint Quentin En Yvelines University, Department of Rheumatology, Ambroise Paré Hospital, APHP, Boulogne-Billancourt, France; Departments of Epidemiology and Biostatistics, and Rheumatology, VU University Medical Center, Amsterdam, The Netherlands; University of Bristol, Academic Rheumatology Unit, Bristol Royal Infirmary, Bristol, UK; Department of Rheumatology, Leiden University Medical Center, Leiden, The Netherlands; Copenhagen Center for Arthritis Research, Center for Rheumatology and Spine Diseases, Copenhagen University Hospital Glostrup, Copenhagen, Denmark; Department of Internal Medicine 3 and Institute for Clinical Immunology, University of Erlangen-Nuremberg, Erlangen, Germany; Department of Clinical Immunology and Rheumatology, Academic Medical Center, University of Amsterdam and Atrium Medical Center, Amsterdam, The Netherlands; Department of Medicine, University of Alberta, Edmonton, Alberta, Canada; Department of Rheumatology, Hospital General Universitario Gregorio Marañón, Madrid, Spain; Paris-Descartes University, Medicine Faculty, APHP, Cochin Hospital, Rheumatology B, Paris, France; Rheumatology Unit, Sapienza Università di Roma, Rome, Italy; Division of Rheumatology, Johns Hopkins University, Baltimore, Maryland, USA; University of Melbourne, Medicine, Dentistry and Health Sciences, Melbourne, Australia; St. Michael’s Hospital, Mobility Program Clinical Research Unit; Institute for Work and Health; University of Toronto, Department of Health Policy, Management and Evaluation, Department of Rehabilitation Science and Department of Occupational Science and Occupational Therapy, Toronto, Ontario, Canada; Pierre et Marie Curie University (UPMC) — Paris, GRCUPMC 08 (EEMOIS); AP-HP Pitié Salpêtrière Hospital, Department of Rheumatology, Paris; Université de Lorraine, Université Paris Descartes, EA 4360 APEMAC, Nancy and Inserm CIC-EC, CHU de Nancy, Nancy, France; Department of Nursing, University of the West of England, Bristol, UK; Swedish Medical Center and University of Washington, Seattle, Washington, USA; Instituto Poal, Barcelona, Spain; SDG LLC, Cambridge, Massachusetts; Birmingham Veterans Affairs Medical Center and University of Alabama at Birmingham, Birmingham, Alabama; Division of Immunology/Rheumatology, Stanford University School of Medicine, Palo Alto, California, USA; Leeds Institute of Rheumatic and Musculoskeletal Medicine, University of Leeds, and UK National Institute for Health Research, Leeds Musculoskeletal Biomedical Research Unit, Leeds, UK; Department of Epidemiology and Community Medicine, and Department of Medicine, University of Ottawa, Ottawa, Ontario, Canada. M-A. D’Agostino, MD, PhD, Versailles-Saint Quentin En Yvelines University, Department of Rheumatology, Ambroise Paré Hospital, APHP; M. Boers, MD, PhD, Departments of Epidemiology and Biostatistics, and Rheumatology, VU University Medical Center; J.R. Kirwan, MD, University of Bristol, Academic Rheumatology Unit, Bristol Royal Infirmary; D.M. van der Heijde, MD, PhD, Department of Rheumatology, Leiden University Medical Center; M. Østergaard, MD, PhD, DMSc, Copenhagen Center for Arthritis Research, Center for Rheumatology and Spine Diseases, Copenhagen University Hospital Glostrup; G. Schett, MD, Department of Internal Medicine 3 and Institute for Clinical Immunology, University of Erlangen-Nuremberg; R.B. Landewé, MD, PhD, Department of Clinical Immunology and Rheumatology, Academic Medical Center, University of Amsterdam and Atrium Medical Center; W.P. Maksymowych, FRCPC, Department of Medicine, University of Alberta; E. Naredo, MD, Department of Rheumatology, Hospital General Universitario Gregorio Marañón; M. Dougados, MD, Paris-Descartes University, Medicine Faculty, APHP, Cochin Hospital, Rheumatology B; A. Iagnocco, MD, Rheumatology Unit, Sapienza Università di Roma; C.O. Bingham III, MD, Division of Rheumatology, Johns Hopkins University; P. Brooks, MD, FRACP, University of Melbourne, Medicine, Dentistry and Health Sciences; D.E. Beaton, BScOT, PhD, Department of Occupational Sciences and Occupational Therapy, Institute for Health Policy Management and Evaluation, University of Toronto; F. Gandjbakhch, MD; Laure Gossec, MD, PhD, UPMC, GRC-UPMC 08 (EEMOIS); AP-HP Pitié Salpêtrière Hospital, Department of Rheumatology; F. Guillemin, MD, PhD, Université de Lorraine, Université Paris Descartes, EA 4360 APEMAC, Nancy and Inserm CIC-EC, CHU de Nancy; S. Hewlett, PhD, RN, Department of Nursing, University of the West of England; M. Kloppenburg, MD, PhD, Department of Rheumatology, Leiden University Medical Center; P.J. Mease, MD, Swedish Medical Center and University of Washington; I. Moller, MD, Instituto Poal; L.S. Simon, MD, SDG LLC; J.A. Singh, MD, MPH, Birmingham Veterans Affairs Medical Center and University of Alabama at Birmingham; V. Strand, MD, Division of Immunology/Rheumatology, Stanford University School of Medicine; R.J. Wakefield BM, MD, FRCP, Leeds Institute of Rheumatic and Musculoskeletal Medicine, University of Leeds, and NIHR, Leeds Musculoskeletal Biomedical Research Unit; G. Wells, Epidemiology and Community Medicine; P. Tugwell, MD, Department of Medicine, University of Ottawa; P.G. Conaghan, MB, BS, PhD, FRACP, FRCP, Leeds Institute of Rheumatic and Musculoskeletal Medicine, University of Leeds, and NIHR, Leeds Musculoskeletal Biomedical Research Unit. Address correspondence to Prof. D’Agostino, Rheumatology Department, APHP Ambroise Paré Hospital, 9 avenue Charles de Gaulle, 92100 Boulogne-Billancourt, France. E-mail: mariaantonietta.dagostino@apr.aphp.fr
Esperanza Naredo
From Versailles-Saint Quentin En Yvelines University, Department of Rheumatology, Ambroise Paré Hospital, APHP, Boulogne-Billancourt, France; Departments of Epidemiology and Biostatistics, and Rheumatology, VU University Medical Center, Amsterdam, The Netherlands; University of Bristol, Academic Rheumatology Unit, Bristol Royal Infirmary, Bristol, UK; Department of Rheumatology, Leiden University Medical Center, Leiden, The Netherlands; Copenhagen Center for Arthritis Research, Center for Rheumatology and Spine Diseases, Copenhagen University Hospital Glostrup, Copenhagen, Denmark; Department of Internal Medicine 3 and Institute for Clinical Immunology, University of Erlangen-Nuremberg, Erlangen, Germany; Department of Clinical Immunology and Rheumatology, Academic Medical Center, University of Amsterdam and Atrium Medical Center, Amsterdam, The Netherlands; Department of Medicine, University of Alberta, Edmonton, Alberta, Canada; Department of Rheumatology, Hospital General Universitario Gregorio Marañón, Madrid, Spain; Paris-Descartes University, Medicine Faculty, APHP, Cochin Hospital, Rheumatology B, Paris, France; Rheumatology Unit, Sapienza Università di Roma, Rome, Italy; Division of Rheumatology, Johns Hopkins University, Baltimore, Maryland, USA; University of Melbourne, Medicine, Dentistry and Health Sciences, Melbourne, Australia; St. Michael’s Hospital, Mobility Program Clinical Research Unit; Institute for Work and Health; University of Toronto, Department of Health Policy, Management and Evaluation, Department of Rehabilitation Science and Department of Occupational Science and Occupational Therapy, Toronto, Ontario, Canada; Pierre et Marie Curie University (UPMC) — Paris, GRCUPMC 08 (EEMOIS); AP-HP Pitié Salpêtrière Hospital, Department of Rheumatology, Paris; Université de Lorraine, Université Paris Descartes, EA 4360 APEMAC, Nancy and Inserm CIC-EC, CHU de Nancy, Nancy, France; Department of Nursing, University of the West of England, Bristol, UK; Swedish Medical Center and University of Washington, Seattle, Washington, USA; Instituto Poal, Barcelona, Spain; SDG LLC, Cambridge, Massachusetts; Birmingham Veterans Affairs Medical Center and University of Alabama at Birmingham, Birmingham, Alabama; Division of Immunology/Rheumatology, Stanford University School of Medicine, Palo Alto, California, USA; Leeds Institute of Rheumatic and Musculoskeletal Medicine, University of Leeds, and UK National Institute for Health Research, Leeds Musculoskeletal Biomedical Research Unit, Leeds, UK; Department of Epidemiology and Community Medicine, and Department of Medicine, University of Ottawa, Ottawa, Ontario, Canada. M-A. D’Agostino, MD, PhD, Versailles-Saint Quentin En Yvelines University, Department of Rheumatology, Ambroise Paré Hospital, APHP; M. Boers, MD, PhD, Departments of Epidemiology and Biostatistics, and Rheumatology, VU University Medical Center; J.R. Kirwan, MD, University of Bristol, Academic Rheumatology Unit, Bristol Royal Infirmary; D.M. van der Heijde, MD, PhD, Department of Rheumatology, Leiden University Medical Center; M. Østergaard, MD, PhD, DMSc, Copenhagen Center for Arthritis Research, Center for Rheumatology and Spine Diseases, Copenhagen University Hospital Glostrup; G. Schett, MD, Department of Internal Medicine 3 and Institute for Clinical Immunology, University of Erlangen-Nuremberg; R.B. Landewé, MD, PhD, Department of Clinical Immunology and Rheumatology, Academic Medical Center, University of Amsterdam and Atrium Medical Center; W.P. Maksymowych, FRCPC, Department of Medicine, University of Alberta; E. Naredo, MD, Department of Rheumatology, Hospital General Universitario Gregorio Marañón; M. Dougados, MD, Paris-Descartes University, Medicine Faculty, APHP, Cochin Hospital, Rheumatology B; A. Iagnocco, MD, Rheumatology Unit, Sapienza Università di Roma; C.O. Bingham III, MD, Division of Rheumatology, Johns Hopkins University; P. Brooks, MD, FRACP, University of Melbourne, Medicine, Dentistry and Health Sciences; D.E. Beaton, BScOT, PhD, Department of Occupational Sciences and Occupational Therapy, Institute for Health Policy Management and Evaluation, University of Toronto; F. Gandjbakhch, MD; Laure Gossec, MD, PhD, UPMC, GRC-UPMC 08 (EEMOIS); AP-HP Pitié Salpêtrière Hospital, Department of Rheumatology; F. Guillemin, MD, PhD, Université de Lorraine, Université Paris Descartes, EA 4360 APEMAC, Nancy and Inserm CIC-EC, CHU de Nancy; S. Hewlett, PhD, RN, Department of Nursing, University of the West of England; M. Kloppenburg, MD, PhD, Department of Rheumatology, Leiden University Medical Center; P.J. Mease, MD, Swedish Medical Center and University of Washington; I. Moller, MD, Instituto Poal; L.S. Simon, MD, SDG LLC; J.A. Singh, MD, MPH, Birmingham Veterans Affairs Medical Center and University of Alabama at Birmingham; V. Strand, MD, Division of Immunology/Rheumatology, Stanford University School of Medicine; R.J. Wakefield BM, MD, FRCP, Leeds Institute of Rheumatic and Musculoskeletal Medicine, University of Leeds, and NIHR, Leeds Musculoskeletal Biomedical Research Unit; G. Wells, Epidemiology and Community Medicine; P. Tugwell, MD, Department of Medicine, University of Ottawa; P.G. Conaghan, MB, BS, PhD, FRACP, FRCP, Leeds Institute of Rheumatic and Musculoskeletal Medicine, University of Leeds, and NIHR, Leeds Musculoskeletal Biomedical Research Unit. Address correspondence to Prof. D’Agostino, Rheumatology Department, APHP Ambroise Paré Hospital, 9 avenue Charles de Gaulle, 92100 Boulogne-Billancourt, France. E-mail: mariaantonietta.dagostino@apr.aphp.fr
Maxime Dougados
From Versailles-Saint Quentin En Yvelines University, Department of Rheumatology, Ambroise Paré Hospital, APHP, Boulogne-Billancourt, France; Departments of Epidemiology and Biostatistics, and Rheumatology, VU University Medical Center, Amsterdam, The Netherlands; University of Bristol, Academic Rheumatology Unit, Bristol Royal Infirmary, Bristol, UK; Department of Rheumatology, Leiden University Medical Center, Leiden, The Netherlands; Copenhagen Center for Arthritis Research, Center for Rheumatology and Spine Diseases, Copenhagen University Hospital Glostrup, Copenhagen, Denmark; Department of Internal Medicine 3 and Institute for Clinical Immunology, University of Erlangen-Nuremberg, Erlangen, Germany; Department of Clinical Immunology and Rheumatology, Academic Medical Center, University of Amsterdam and Atrium Medical Center, Amsterdam, The Netherlands; Department of Medicine, University of Alberta, Edmonton, Alberta, Canada; Department of Rheumatology, Hospital General Universitario Gregorio Marañón, Madrid, Spain; Paris-Descartes University, Medicine Faculty, APHP, Cochin Hospital, Rheumatology B, Paris, France; Rheumatology Unit, Sapienza Università di Roma, Rome, Italy; Division of Rheumatology, Johns Hopkins University, Baltimore, Maryland, USA; University of Melbourne, Medicine, Dentistry and Health Sciences, Melbourne, Australia; St. Michael’s Hospital, Mobility Program Clinical Research Unit; Institute for Work and Health; University of Toronto, Department of Health Policy, Management and Evaluation, Department of Rehabilitation Science and Department of Occupational Science and Occupational Therapy, Toronto, Ontario, Canada; Pierre et Marie Curie University (UPMC) — Paris, GRCUPMC 08 (EEMOIS); AP-HP Pitié Salpêtrière Hospital, Department of Rheumatology, Paris; Université de Lorraine, Université Paris Descartes, EA 4360 APEMAC, Nancy and Inserm CIC-EC, CHU de Nancy, Nancy, France; Department of Nursing, University of the West of England, Bristol, UK; Swedish Medical Center and University of Washington, Seattle, Washington, USA; Instituto Poal, Barcelona, Spain; SDG LLC, Cambridge, Massachusetts; Birmingham Veterans Affairs Medical Center and University of Alabama at Birmingham, Birmingham, Alabama; Division of Immunology/Rheumatology, Stanford University School of Medicine, Palo Alto, California, USA; Leeds Institute of Rheumatic and Musculoskeletal Medicine, University of Leeds, and UK National Institute for Health Research, Leeds Musculoskeletal Biomedical Research Unit, Leeds, UK; Department of Epidemiology and Community Medicine, and Department of Medicine, University of Ottawa, Ottawa, Ontario, Canada. M-A. D’Agostino, MD, PhD, Versailles-Saint Quentin En Yvelines University, Department of Rheumatology, Ambroise Paré Hospital, APHP; M. Boers, MD, PhD, Departments of Epidemiology and Biostatistics, and Rheumatology, VU University Medical Center; J.R. Kirwan, MD, University of Bristol, Academic Rheumatology Unit, Bristol Royal Infirmary; D.M. van der Heijde, MD, PhD, Department of Rheumatology, Leiden University Medical Center; M. Østergaard, MD, PhD, DMSc, Copenhagen Center for Arthritis Research, Center for Rheumatology and Spine Diseases, Copenhagen University Hospital Glostrup; G. Schett, MD, Department of Internal Medicine 3 and Institute for Clinical Immunology, University of Erlangen-Nuremberg; R.B. Landewé, MD, PhD, Department of Clinical Immunology and Rheumatology, Academic Medical Center, University of Amsterdam and Atrium Medical Center; W.P. Maksymowych, FRCPC, Department of Medicine, University of Alberta; E. Naredo, MD, Department of Rheumatology, Hospital General Universitario Gregorio Marañón; M. Dougados, MD, Paris-Descartes University, Medicine Faculty, APHP, Cochin Hospital, Rheumatology B; A. Iagnocco, MD, Rheumatology Unit, Sapienza Università di Roma; C.O. Bingham III, MD, Division of Rheumatology, Johns Hopkins University; P. Brooks, MD, FRACP, University of Melbourne, Medicine, Dentistry and Health Sciences; D.E. Beaton, BScOT, PhD, Department of Occupational Sciences and Occupational Therapy, Institute for Health Policy Management and Evaluation, University of Toronto; F. Gandjbakhch, MD; Laure Gossec, MD, PhD, UPMC, GRC-UPMC 08 (EEMOIS); AP-HP Pitié Salpêtrière Hospital, Department of Rheumatology; F. Guillemin, MD, PhD, Université de Lorraine, Université Paris Descartes, EA 4360 APEMAC, Nancy and Inserm CIC-EC, CHU de Nancy; S. Hewlett, PhD, RN, Department of Nursing, University of the West of England; M. Kloppenburg, MD, PhD, Department of Rheumatology, Leiden University Medical Center; P.J. Mease, MD, Swedish Medical Center and University of Washington; I. Moller, MD, Instituto Poal; L.S. Simon, MD, SDG LLC; J.A. Singh, MD, MPH, Birmingham Veterans Affairs Medical Center and University of Alabama at Birmingham; V. Strand, MD, Division of Immunology/Rheumatology, Stanford University School of Medicine; R.J. Wakefield BM, MD, FRCP, Leeds Institute of Rheumatic and Musculoskeletal Medicine, University of Leeds, and NIHR, Leeds Musculoskeletal Biomedical Research Unit; G. Wells, Epidemiology and Community Medicine; P. Tugwell, MD, Department of Medicine, University of Ottawa; P.G. Conaghan, MB, BS, PhD, FRACP, FRCP, Leeds Institute of Rheumatic and Musculoskeletal Medicine, University of Leeds, and NIHR, Leeds Musculoskeletal Biomedical Research Unit. Address correspondence to Prof. D’Agostino, Rheumatology Department, APHP Ambroise Paré Hospital, 9 avenue Charles de Gaulle, 92100 Boulogne-Billancourt, France. E-mail: mariaantonietta.dagostino@apr.aphp.fr
Annamaria Iagnocco
From Versailles-Saint Quentin En Yvelines University, Department of Rheumatology, Ambroise Paré Hospital, APHP, Boulogne-Billancourt, France; Departments of Epidemiology and Biostatistics, and Rheumatology, VU University Medical Center, Amsterdam, The Netherlands; University of Bristol, Academic Rheumatology Unit, Bristol Royal Infirmary, Bristol, UK; Department of Rheumatology, Leiden University Medical Center, Leiden, The Netherlands; Copenhagen Center for Arthritis Research, Center for Rheumatology and Spine Diseases, Copenhagen University Hospital Glostrup, Copenhagen, Denmark; Department of Internal Medicine 3 and Institute for Clinical Immunology, University of Erlangen-Nuremberg, Erlangen, Germany; Department of Clinical Immunology and Rheumatology, Academic Medical Center, University of Amsterdam and Atrium Medical Center, Amsterdam, The Netherlands; Department of Medicine, University of Alberta, Edmonton, Alberta, Canada; Department of Rheumatology, Hospital General Universitario Gregorio Marañón, Madrid, Spain; Paris-Descartes University, Medicine Faculty, APHP, Cochin Hospital, Rheumatology B, Paris, France; Rheumatology Unit, Sapienza Università di Roma, Rome, Italy; Division of Rheumatology, Johns Hopkins University, Baltimore, Maryland, USA; University of Melbourne, Medicine, Dentistry and Health Sciences, Melbourne, Australia; St. Michael’s Hospital, Mobility Program Clinical Research Unit; Institute for Work and Health; University of Toronto, Department of Health Policy, Management and Evaluation, Department of Rehabilitation Science and Department of Occupational Science and Occupational Therapy, Toronto, Ontario, Canada; Pierre et Marie Curie University (UPMC) — Paris, GRCUPMC 08 (EEMOIS); AP-HP Pitié Salpêtrière Hospital, Department of Rheumatology, Paris; Université de Lorraine, Université Paris Descartes, EA 4360 APEMAC, Nancy and Inserm CIC-EC, CHU de Nancy, Nancy, France; Department of Nursing, University of the West of England, Bristol, UK; Swedish Medical Center and University of Washington, Seattle, Washington, USA; Instituto Poal, Barcelona, Spain; SDG LLC, Cambridge, Massachusetts; Birmingham Veterans Affairs Medical Center and University of Alabama at Birmingham, Birmingham, Alabama; Division of Immunology/Rheumatology, Stanford University School of Medicine, Palo Alto, California, USA; Leeds Institute of Rheumatic and Musculoskeletal Medicine, University of Leeds, and UK National Institute for Health Research, Leeds Musculoskeletal Biomedical Research Unit, Leeds, UK; Department of Epidemiology and Community Medicine, and Department of Medicine, University of Ottawa, Ottawa, Ontario, Canada. M-A. D’Agostino, MD, PhD, Versailles-Saint Quentin En Yvelines University, Department of Rheumatology, Ambroise Paré Hospital, APHP; M. Boers, MD, PhD, Departments of Epidemiology and Biostatistics, and Rheumatology, VU University Medical Center; J.R. Kirwan, MD, University of Bristol, Academic Rheumatology Unit, Bristol Royal Infirmary; D.M. van der Heijde, MD, PhD, Department of Rheumatology, Leiden University Medical Center; M. Østergaard, MD, PhD, DMSc, Copenhagen Center for Arthritis Research, Center for Rheumatology and Spine Diseases, Copenhagen University Hospital Glostrup; G. Schett, MD, Department of Internal Medicine 3 and Institute for Clinical Immunology, University of Erlangen-Nuremberg; R.B. Landewé, MD, PhD, Department of Clinical Immunology and Rheumatology, Academic Medical Center, University of Amsterdam and Atrium Medical Center; W.P. Maksymowych, FRCPC, Department of Medicine, University of Alberta; E. Naredo, MD, Department of Rheumatology, Hospital General Universitario Gregorio Marañón; M. Dougados, MD, Paris-Descartes University, Medicine Faculty, APHP, Cochin Hospital, Rheumatology B; A. Iagnocco, MD, Rheumatology Unit, Sapienza Università di Roma; C.O. Bingham III, MD, Division of Rheumatology, Johns Hopkins University; P. Brooks, MD, FRACP, University of Melbourne, Medicine, Dentistry and Health Sciences; D.E. Beaton, BScOT, PhD, Department of Occupational Sciences and Occupational Therapy, Institute for Health Policy Management and Evaluation, University of Toronto; F. Gandjbakhch, MD; Laure Gossec, MD, PhD, UPMC, GRC-UPMC 08 (EEMOIS); AP-HP Pitié Salpêtrière Hospital, Department of Rheumatology; F. Guillemin, MD, PhD, Université de Lorraine, Université Paris Descartes, EA 4360 APEMAC, Nancy and Inserm CIC-EC, CHU de Nancy; S. Hewlett, PhD, RN, Department of Nursing, University of the West of England; M. Kloppenburg, MD, PhD, Department of Rheumatology, Leiden University Medical Center; P.J. Mease, MD, Swedish Medical Center and University of Washington; I. Moller, MD, Instituto Poal; L.S. Simon, MD, SDG LLC; J.A. Singh, MD, MPH, Birmingham Veterans Affairs Medical Center and University of Alabama at Birmingham; V. Strand, MD, Division of Immunology/Rheumatology, Stanford University School of Medicine; R.J. Wakefield BM, MD, FRCP, Leeds Institute of Rheumatic and Musculoskeletal Medicine, University of Leeds, and NIHR, Leeds Musculoskeletal Biomedical Research Unit; G. Wells, Epidemiology and Community Medicine; P. Tugwell, MD, Department of Medicine, University of Ottawa; P.G. Conaghan, MB, BS, PhD, FRACP, FRCP, Leeds Institute of Rheumatic and Musculoskeletal Medicine, University of Leeds, and NIHR, Leeds Musculoskeletal Biomedical Research Unit. Address correspondence to Prof. D’Agostino, Rheumatology Department, APHP Ambroise Paré Hospital, 9 avenue Charles de Gaulle, 92100 Boulogne-Billancourt, France. E-mail: mariaantonietta.dagostino@apr.aphp.fr
Clifton O. Bingham III
From Versailles-Saint Quentin En Yvelines University, Department of Rheumatology, Ambroise Paré Hospital, APHP, Boulogne-Billancourt, France; Departments of Epidemiology and Biostatistics, and Rheumatology, VU University Medical Center, Amsterdam, The Netherlands; University of Bristol, Academic Rheumatology Unit, Bristol Royal Infirmary, Bristol, UK; Department of Rheumatology, Leiden University Medical Center, Leiden, The Netherlands; Copenhagen Center for Arthritis Research, Center for Rheumatology and Spine Diseases, Copenhagen University Hospital Glostrup, Copenhagen, Denmark; Department of Internal Medicine 3 and Institute for Clinical Immunology, University of Erlangen-Nuremberg, Erlangen, Germany; Department of Clinical Immunology and Rheumatology, Academic Medical Center, University of Amsterdam and Atrium Medical Center, Amsterdam, The Netherlands; Department of Medicine, University of Alberta, Edmonton, Alberta, Canada; Department of Rheumatology, Hospital General Universitario Gregorio Marañón, Madrid, Spain; Paris-Descartes University, Medicine Faculty, APHP, Cochin Hospital, Rheumatology B, Paris, France; Rheumatology Unit, Sapienza Università di Roma, Rome, Italy; Division of Rheumatology, Johns Hopkins University, Baltimore, Maryland, USA; University of Melbourne, Medicine, Dentistry and Health Sciences, Melbourne, Australia; St. Michael’s Hospital, Mobility Program Clinical Research Unit; Institute for Work and Health; University of Toronto, Department of Health Policy, Management and Evaluation, Department of Rehabilitation Science and Department of Occupational Science and Occupational Therapy, Toronto, Ontario, Canada; Pierre et Marie Curie University (UPMC) — Paris, GRCUPMC 08 (EEMOIS); AP-HP Pitié Salpêtrière Hospital, Department of Rheumatology, Paris; Université de Lorraine, Université Paris Descartes, EA 4360 APEMAC, Nancy and Inserm CIC-EC, CHU de Nancy, Nancy, France; Department of Nursing, University of the West of England, Bristol, UK; Swedish Medical Center and University of Washington, Seattle, Washington, USA; Instituto Poal, Barcelona, Spain; SDG LLC, Cambridge, Massachusetts; Birmingham Veterans Affairs Medical Center and University of Alabama at Birmingham, Birmingham, Alabama; Division of Immunology/Rheumatology, Stanford University School of Medicine, Palo Alto, California, USA; Leeds Institute of Rheumatic and Musculoskeletal Medicine, University of Leeds, and UK National Institute for Health Research, Leeds Musculoskeletal Biomedical Research Unit, Leeds, UK; Department of Epidemiology and Community Medicine, and Department of Medicine, University of Ottawa, Ottawa, Ontario, Canada. M-A. D’Agostino, MD, PhD, Versailles-Saint Quentin En Yvelines University, Department of Rheumatology, Ambroise Paré Hospital, APHP; M. Boers, MD, PhD, Departments of Epidemiology and Biostatistics, and Rheumatology, VU University Medical Center; J.R. Kirwan, MD, University of Bristol, Academic Rheumatology Unit, Bristol Royal Infirmary; D.M. van der Heijde, MD, PhD, Department of Rheumatology, Leiden University Medical Center; M. Østergaard, MD, PhD, DMSc, Copenhagen Center for Arthritis Research, Center for Rheumatology and Spine Diseases, Copenhagen University Hospital Glostrup; G. Schett, MD, Department of Internal Medicine 3 and Institute for Clinical Immunology, University of Erlangen-Nuremberg; R.B. Landewé, MD, PhD, Department of Clinical Immunology and Rheumatology, Academic Medical Center, University of Amsterdam and Atrium Medical Center; W.P. Maksymowych, FRCPC, Department of Medicine, University of Alberta; E. Naredo, MD, Department of Rheumatology, Hospital General Universitario Gregorio Marañón; M. Dougados, MD, Paris-Descartes University, Medicine Faculty, APHP, Cochin Hospital, Rheumatology B; A. Iagnocco, MD, Rheumatology Unit, Sapienza Università di Roma; C.O. Bingham III, MD, Division of Rheumatology, Johns Hopkins University; P. Brooks, MD, FRACP, University of Melbourne, Medicine, Dentistry and Health Sciences; D.E. Beaton, BScOT, PhD, Department of Occupational Sciences and Occupational Therapy, Institute for Health Policy Management and Evaluation, University of Toronto; F. Gandjbakhch, MD; Laure Gossec, MD, PhD, UPMC, GRC-UPMC 08 (EEMOIS); AP-HP Pitié Salpêtrière Hospital, Department of Rheumatology; F. Guillemin, MD, PhD, Université de Lorraine, Université Paris Descartes, EA 4360 APEMAC, Nancy and Inserm CIC-EC, CHU de Nancy; S. Hewlett, PhD, RN, Department of Nursing, University of the West of England; M. Kloppenburg, MD, PhD, Department of Rheumatology, Leiden University Medical Center; P.J. Mease, MD, Swedish Medical Center and University of Washington; I. Moller, MD, Instituto Poal; L.S. Simon, MD, SDG LLC; J.A. Singh, MD, MPH, Birmingham Veterans Affairs Medical Center and University of Alabama at Birmingham; V. Strand, MD, Division of Immunology/Rheumatology, Stanford University School of Medicine; R.J. Wakefield BM, MD, FRCP, Leeds Institute of Rheumatic and Musculoskeletal Medicine, University of Leeds, and NIHR, Leeds Musculoskeletal Biomedical Research Unit; G. Wells, Epidemiology and Community Medicine; P. Tugwell, MD, Department of Medicine, University of Ottawa; P.G. Conaghan, MB, BS, PhD, FRACP, FRCP, Leeds Institute of Rheumatic and Musculoskeletal Medicine, University of Leeds, and NIHR, Leeds Musculoskeletal Biomedical Research Unit. Address correspondence to Prof. D’Agostino, Rheumatology Department, APHP Ambroise Paré Hospital, 9 avenue Charles de Gaulle, 92100 Boulogne-Billancourt, France. E-mail: mariaantonietta.dagostino@apr.aphp.fr
Peter M. Brooks
From Versailles-Saint Quentin En Yvelines University, Department of Rheumatology, Ambroise Paré Hospital, APHP, Boulogne-Billancourt, France; Departments of Epidemiology and Biostatistics, and Rheumatology, VU University Medical Center, Amsterdam, The Netherlands; University of Bristol, Academic Rheumatology Unit, Bristol Royal Infirmary, Bristol, UK; Department of Rheumatology, Leiden University Medical Center, Leiden, The Netherlands; Copenhagen Center for Arthritis Research, Center for Rheumatology and Spine Diseases, Copenhagen University Hospital Glostrup, Copenhagen, Denmark; Department of Internal Medicine 3 and Institute for Clinical Immunology, University of Erlangen-Nuremberg, Erlangen, Germany; Department of Clinical Immunology and Rheumatology, Academic Medical Center, University of Amsterdam and Atrium Medical Center, Amsterdam, The Netherlands; Department of Medicine, University of Alberta, Edmonton, Alberta, Canada; Department of Rheumatology, Hospital General Universitario Gregorio Marañón, Madrid, Spain; Paris-Descartes University, Medicine Faculty, APHP, Cochin Hospital, Rheumatology B, Paris, France; Rheumatology Unit, Sapienza Università di Roma, Rome, Italy; Division of Rheumatology, Johns Hopkins University, Baltimore, Maryland, USA; University of Melbourne, Medicine, Dentistry and Health Sciences, Melbourne, Australia; St. Michael’s Hospital, Mobility Program Clinical Research Unit; Institute for Work and Health; University of Toronto, Department of Health Policy, Management and Evaluation, Department of Rehabilitation Science and Department of Occupational Science and Occupational Therapy, Toronto, Ontario, Canada; Pierre et Marie Curie University (UPMC) — Paris, GRCUPMC 08 (EEMOIS); AP-HP Pitié Salpêtrière Hospital, Department of Rheumatology, Paris; Université de Lorraine, Université Paris Descartes, EA 4360 APEMAC, Nancy and Inserm CIC-EC, CHU de Nancy, Nancy, France; Department of Nursing, University of the West of England, Bristol, UK; Swedish Medical Center and University of Washington, Seattle, Washington, USA; Instituto Poal, Barcelona, Spain; SDG LLC, Cambridge, Massachusetts; Birmingham Veterans Affairs Medical Center and University of Alabama at Birmingham, Birmingham, Alabama; Division of Immunology/Rheumatology, Stanford University School of Medicine, Palo Alto, California, USA; Leeds Institute of Rheumatic and Musculoskeletal Medicine, University of Leeds, and UK National Institute for Health Research, Leeds Musculoskeletal Biomedical Research Unit, Leeds, UK; Department of Epidemiology and Community Medicine, and Department of Medicine, University of Ottawa, Ottawa, Ontario, Canada. M-A. D’Agostino, MD, PhD, Versailles-Saint Quentin En Yvelines University, Department of Rheumatology, Ambroise Paré Hospital, APHP; M. Boers, MD, PhD, Departments of Epidemiology and Biostatistics, and Rheumatology, VU University Medical Center; J.R. Kirwan, MD, University of Bristol, Academic Rheumatology Unit, Bristol Royal Infirmary; D.M. van der Heijde, MD, PhD, Department of Rheumatology, Leiden University Medical Center; M. Østergaard, MD, PhD, DMSc, Copenhagen Center for Arthritis Research, Center for Rheumatology and Spine Diseases, Copenhagen University Hospital Glostrup; G. Schett, MD, Department of Internal Medicine 3 and Institute for Clinical Immunology, University of Erlangen-Nuremberg; R.B. Landewé, MD, PhD, Department of Clinical Immunology and Rheumatology, Academic Medical Center, University of Amsterdam and Atrium Medical Center; W.P. Maksymowych, FRCPC, Department of Medicine, University of Alberta; E. Naredo, MD, Department of Rheumatology, Hospital General Universitario Gregorio Marañón; M. Dougados, MD, Paris-Descartes University, Medicine Faculty, APHP, Cochin Hospital, Rheumatology B; A. Iagnocco, MD, Rheumatology Unit, Sapienza Università di Roma; C.O. Bingham III, MD, Division of Rheumatology, Johns Hopkins University; P. Brooks, MD, FRACP, University of Melbourne, Medicine, Dentistry and Health Sciences; D.E. Beaton, BScOT, PhD, Department of Occupational Sciences and Occupational Therapy, Institute for Health Policy Management and Evaluation, University of Toronto; F. Gandjbakhch, MD; Laure Gossec, MD, PhD, UPMC, GRC-UPMC 08 (EEMOIS); AP-HP Pitié Salpêtrière Hospital, Department of Rheumatology; F. Guillemin, MD, PhD, Université de Lorraine, Université Paris Descartes, EA 4360 APEMAC, Nancy and Inserm CIC-EC, CHU de Nancy; S. Hewlett, PhD, RN, Department of Nursing, University of the West of England; M. Kloppenburg, MD, PhD, Department of Rheumatology, Leiden University Medical Center; P.J. Mease, MD, Swedish Medical Center and University of Washington; I. Moller, MD, Instituto Poal; L.S. Simon, MD, SDG LLC; J.A. Singh, MD, MPH, Birmingham Veterans Affairs Medical Center and University of Alabama at Birmingham; V. Strand, MD, Division of Immunology/Rheumatology, Stanford University School of Medicine; R.J. Wakefield BM, MD, FRCP, Leeds Institute of Rheumatic and Musculoskeletal Medicine, University of Leeds, and NIHR, Leeds Musculoskeletal Biomedical Research Unit; G. Wells, Epidemiology and Community Medicine; P. Tugwell, MD, Department of Medicine, University of Ottawa; P.G. Conaghan, MB, BS, PhD, FRACP, FRCP, Leeds Institute of Rheumatic and Musculoskeletal Medicine, University of Leeds, and NIHR, Leeds Musculoskeletal Biomedical Research Unit. Address correspondence to Prof. D’Agostino, Rheumatology Department, APHP Ambroise Paré Hospital, 9 avenue Charles de Gaulle, 92100 Boulogne-Billancourt, France. E-mail: mariaantonietta.dagostino@apr.aphp.fr
Dorcas E. Beaton
From Versailles-Saint Quentin En Yvelines University, Department of Rheumatology, Ambroise Paré Hospital, APHP, Boulogne-Billancourt, France; Departments of Epidemiology and Biostatistics, and Rheumatology, VU University Medical Center, Amsterdam, The Netherlands; University of Bristol, Academic Rheumatology Unit, Bristol Royal Infirmary, Bristol, UK; Department of Rheumatology, Leiden University Medical Center, Leiden, The Netherlands; Copenhagen Center for Arthritis Research, Center for Rheumatology and Spine Diseases, Copenhagen University Hospital Glostrup, Copenhagen, Denmark; Department of Internal Medicine 3 and Institute for Clinical Immunology, University of Erlangen-Nuremberg, Erlangen, Germany; Department of Clinical Immunology and Rheumatology, Academic Medical Center, University of Amsterdam and Atrium Medical Center, Amsterdam, The Netherlands; Department of Medicine, University of Alberta, Edmonton, Alberta, Canada; Department of Rheumatology, Hospital General Universitario Gregorio Marañón, Madrid, Spain; Paris-Descartes University, Medicine Faculty, APHP, Cochin Hospital, Rheumatology B, Paris, France; Rheumatology Unit, Sapienza Università di Roma, Rome, Italy; Division of Rheumatology, Johns Hopkins University, Baltimore, Maryland, USA; University of Melbourne, Medicine, Dentistry and Health Sciences, Melbourne, Australia; St. Michael’s Hospital, Mobility Program Clinical Research Unit; Institute for Work and Health; University of Toronto, Department of Health Policy, Management and Evaluation, Department of Rehabilitation Science and Department of Occupational Science and Occupational Therapy, Toronto, Ontario, Canada; Pierre et Marie Curie University (UPMC) — Paris, GRCUPMC 08 (EEMOIS); AP-HP Pitié Salpêtrière Hospital, Department of Rheumatology, Paris; Université de Lorraine, Université Paris Descartes, EA 4360 APEMAC, Nancy and Inserm CIC-EC, CHU de Nancy, Nancy, France; Department of Nursing, University of the West of England, Bristol, UK; Swedish Medical Center and University of Washington, Seattle, Washington, USA; Instituto Poal, Barcelona, Spain; SDG LLC, Cambridge, Massachusetts; Birmingham Veterans Affairs Medical Center and University of Alabama at Birmingham, Birmingham, Alabama; Division of Immunology/Rheumatology, Stanford University School of Medicine, Palo Alto, California, USA; Leeds Institute of Rheumatic and Musculoskeletal Medicine, University of Leeds, and UK National Institute for Health Research, Leeds Musculoskeletal Biomedical Research Unit, Leeds, UK; Department of Epidemiology and Community Medicine, and Department of Medicine, University of Ottawa, Ottawa, Ontario, Canada. M-A. D’Agostino, MD, PhD, Versailles-Saint Quentin En Yvelines University, Department of Rheumatology, Ambroise Paré Hospital, APHP; M. Boers, MD, PhD, Departments of Epidemiology and Biostatistics, and Rheumatology, VU University Medical Center; J.R. Kirwan, MD, University of Bristol, Academic Rheumatology Unit, Bristol Royal Infirmary; D.M. van der Heijde, MD, PhD, Department of Rheumatology, Leiden University Medical Center; M. Østergaard, MD, PhD, DMSc, Copenhagen Center for Arthritis Research, Center for Rheumatology and Spine Diseases, Copenhagen University Hospital Glostrup; G. Schett, MD, Department of Internal Medicine 3 and Institute for Clinical Immunology, University of Erlangen-Nuremberg; R.B. Landewé, MD, PhD, Department of Clinical Immunology and Rheumatology, Academic Medical Center, University of Amsterdam and Atrium Medical Center; W.P. Maksymowych, FRCPC, Department of Medicine, University of Alberta; E. Naredo, MD, Department of Rheumatology, Hospital General Universitario Gregorio Marañón; M. Dougados, MD, Paris-Descartes University, Medicine Faculty, APHP, Cochin Hospital, Rheumatology B; A. Iagnocco, MD, Rheumatology Unit, Sapienza Università di Roma; C.O. Bingham III, MD, Division of Rheumatology, Johns Hopkins University; P. Brooks, MD, FRACP, University of Melbourne, Medicine, Dentistry and Health Sciences; D.E. Beaton, BScOT, PhD, Department of Occupational Sciences and Occupational Therapy, Institute for Health Policy Management and Evaluation, University of Toronto; F. Gandjbakhch, MD; Laure Gossec, MD, PhD, UPMC, GRC-UPMC 08 (EEMOIS); AP-HP Pitié Salpêtrière Hospital, Department of Rheumatology; F. Guillemin, MD, PhD, Université de Lorraine, Université Paris Descartes, EA 4360 APEMAC, Nancy and Inserm CIC-EC, CHU de Nancy; S. Hewlett, PhD, RN, Department of Nursing, University of the West of England; M. Kloppenburg, MD, PhD, Department of Rheumatology, Leiden University Medical Center; P.J. Mease, MD, Swedish Medical Center and University of Washington; I. Moller, MD, Instituto Poal; L.S. Simon, MD, SDG LLC; J.A. Singh, MD, MPH, Birmingham Veterans Affairs Medical Center and University of Alabama at Birmingham; V. Strand, MD, Division of Immunology/Rheumatology, Stanford University School of Medicine; R.J. Wakefield BM, MD, FRCP, Leeds Institute of Rheumatic and Musculoskeletal Medicine, University of Leeds, and NIHR, Leeds Musculoskeletal Biomedical Research Unit; G. Wells, Epidemiology and Community Medicine; P. Tugwell, MD, Department of Medicine, University of Ottawa; P.G. Conaghan, MB, BS, PhD, FRACP, FRCP, Leeds Institute of Rheumatic and Musculoskeletal Medicine, University of Leeds, and NIHR, Leeds Musculoskeletal Biomedical Research Unit. Address correspondence to Prof. D’Agostino, Rheumatology Department, APHP Ambroise Paré Hospital, 9 avenue Charles de Gaulle, 92100 Boulogne-Billancourt, France. E-mail: mariaantonietta.dagostino@apr.aphp.fr
Frederique Gandjbakhch
From Versailles-Saint Quentin En Yvelines University, Department of Rheumatology, Ambroise Paré Hospital, APHP, Boulogne-Billancourt, France; Departments of Epidemiology and Biostatistics, and Rheumatology, VU University Medical Center, Amsterdam, The Netherlands; University of Bristol, Academic Rheumatology Unit, Bristol Royal Infirmary, Bristol, UK; Department of Rheumatology, Leiden University Medical Center, Leiden, The Netherlands; Copenhagen Center for Arthritis Research, Center for Rheumatology and Spine Diseases, Copenhagen University Hospital Glostrup, Copenhagen, Denmark; Department of Internal Medicine 3 and Institute for Clinical Immunology, University of Erlangen-Nuremberg, Erlangen, Germany; Department of Clinical Immunology and Rheumatology, Academic Medical Center, University of Amsterdam and Atrium Medical Center, Amsterdam, The Netherlands; Department of Medicine, University of Alberta, Edmonton, Alberta, Canada; Department of Rheumatology, Hospital General Universitario Gregorio Marañón, Madrid, Spain; Paris-Descartes University, Medicine Faculty, APHP, Cochin Hospital, Rheumatology B, Paris, France; Rheumatology Unit, Sapienza Università di Roma, Rome, Italy; Division of Rheumatology, Johns Hopkins University, Baltimore, Maryland, USA; University of Melbourne, Medicine, Dentistry and Health Sciences, Melbourne, Australia; St. Michael’s Hospital, Mobility Program Clinical Research Unit; Institute for Work and Health; University of Toronto, Department of Health Policy, Management and Evaluation, Department of Rehabilitation Science and Department of Occupational Science and Occupational Therapy, Toronto, Ontario, Canada; Pierre et Marie Curie University (UPMC) — Paris, GRCUPMC 08 (EEMOIS); AP-HP Pitié Salpêtrière Hospital, Department of Rheumatology, Paris; Université de Lorraine, Université Paris Descartes, EA 4360 APEMAC, Nancy and Inserm CIC-EC, CHU de Nancy, Nancy, France; Department of Nursing, University of the West of England, Bristol, UK; Swedish Medical Center and University of Washington, Seattle, Washington, USA; Instituto Poal, Barcelona, Spain; SDG LLC, Cambridge, Massachusetts; Birmingham Veterans Affairs Medical Center and University of Alabama at Birmingham, Birmingham, Alabama; Division of Immunology/Rheumatology, Stanford University School of Medicine, Palo Alto, California, USA; Leeds Institute of Rheumatic and Musculoskeletal Medicine, University of Leeds, and UK National Institute for Health Research, Leeds Musculoskeletal Biomedical Research Unit, Leeds, UK; Department of Epidemiology and Community Medicine, and Department of Medicine, University of Ottawa, Ottawa, Ontario, Canada. M-A. D’Agostino, MD, PhD, Versailles-Saint Quentin En Yvelines University, Department of Rheumatology, Ambroise Paré Hospital, APHP; M. Boers, MD, PhD, Departments of Epidemiology and Biostatistics, and Rheumatology, VU University Medical Center; J.R. Kirwan, MD, University of Bristol, Academic Rheumatology Unit, Bristol Royal Infirmary; D.M. van der Heijde, MD, PhD, Department of Rheumatology, Leiden University Medical Center; M. Østergaard, MD, PhD, DMSc, Copenhagen Center for Arthritis Research, Center for Rheumatology and Spine Diseases, Copenhagen University Hospital Glostrup; G. Schett, MD, Department of Internal Medicine 3 and Institute for Clinical Immunology, University of Erlangen-Nuremberg; R.B. Landewé, MD, PhD, Department of Clinical Immunology and Rheumatology, Academic Medical Center, University of Amsterdam and Atrium Medical Center; W.P. Maksymowych, FRCPC, Department of Medicine, University of Alberta; E. Naredo, MD, Department of Rheumatology, Hospital General Universitario Gregorio Marañón; M. Dougados, MD, Paris-Descartes University, Medicine Faculty, APHP, Cochin Hospital, Rheumatology B; A. Iagnocco, MD, Rheumatology Unit, Sapienza Università di Roma; C.O. Bingham III, MD, Division of Rheumatology, Johns Hopkins University; P. Brooks, MD, FRACP, University of Melbourne, Medicine, Dentistry and Health Sciences; D.E. Beaton, BScOT, PhD, Department of Occupational Sciences and Occupational Therapy, Institute for Health Policy Management and Evaluation, University of Toronto; F. Gandjbakhch, MD; Laure Gossec, MD, PhD, UPMC, GRC-UPMC 08 (EEMOIS); AP-HP Pitié Salpêtrière Hospital, Department of Rheumatology; F. Guillemin, MD, PhD, Université de Lorraine, Université Paris Descartes, EA 4360 APEMAC, Nancy and Inserm CIC-EC, CHU de Nancy; S. Hewlett, PhD, RN, Department of Nursing, University of the West of England; M. Kloppenburg, MD, PhD, Department of Rheumatology, Leiden University Medical Center; P.J. Mease, MD, Swedish Medical Center and University of Washington; I. Moller, MD, Instituto Poal; L.S. Simon, MD, SDG LLC; J.A. Singh, MD, MPH, Birmingham Veterans Affairs Medical Center and University of Alabama at Birmingham; V. Strand, MD, Division of Immunology/Rheumatology, Stanford University School of Medicine; R.J. Wakefield BM, MD, FRCP, Leeds Institute of Rheumatic and Musculoskeletal Medicine, University of Leeds, and NIHR, Leeds Musculoskeletal Biomedical Research Unit; G. Wells, Epidemiology and Community Medicine; P. Tugwell, MD, Department of Medicine, University of Ottawa; P.G. Conaghan, MB, BS, PhD, FRACP, FRCP, Leeds Institute of Rheumatic and Musculoskeletal Medicine, University of Leeds, and NIHR, Leeds Musculoskeletal Biomedical Research Unit. Address correspondence to Prof. D’Agostino, Rheumatology Department, APHP Ambroise Paré Hospital, 9 avenue Charles de Gaulle, 92100 Boulogne-Billancourt, France. E-mail: mariaantonietta.dagostino@apr.aphp.fr
Laure Gossec
From Versailles-Saint Quentin En Yvelines University, Department of Rheumatology, Ambroise Paré Hospital, APHP, Boulogne-Billancourt, France; Departments of Epidemiology and Biostatistics, and Rheumatology, VU University Medical Center, Amsterdam, The Netherlands; University of Bristol, Academic Rheumatology Unit, Bristol Royal Infirmary, Bristol, UK; Department of Rheumatology, Leiden University Medical Center, Leiden, The Netherlands; Copenhagen Center for Arthritis Research, Center for Rheumatology and Spine Diseases, Copenhagen University Hospital Glostrup, Copenhagen, Denmark; Department of Internal Medicine 3 and Institute for Clinical Immunology, University of Erlangen-Nuremberg, Erlangen, Germany; Department of Clinical Immunology and Rheumatology, Academic Medical Center, University of Amsterdam and Atrium Medical Center, Amsterdam, The Netherlands; Department of Medicine, University of Alberta, Edmonton, Alberta, Canada; Department of Rheumatology, Hospital General Universitario Gregorio Marañón, Madrid, Spain; Paris-Descartes University, Medicine Faculty, APHP, Cochin Hospital, Rheumatology B, Paris, France; Rheumatology Unit, Sapienza Università di Roma, Rome, Italy; Division of Rheumatology, Johns Hopkins University, Baltimore, Maryland, USA; University of Melbourne, Medicine, Dentistry and Health Sciences, Melbourne, Australia; St. Michael’s Hospital, Mobility Program Clinical Research Unit; Institute for Work and Health; University of Toronto, Department of Health Policy, Management and Evaluation, Department of Rehabilitation Science and Department of Occupational Science and Occupational Therapy, Toronto, Ontario, Canada; Pierre et Marie Curie University (UPMC) — Paris, GRCUPMC 08 (EEMOIS); AP-HP Pitié Salpêtrière Hospital, Department of Rheumatology, Paris; Université de Lorraine, Université Paris Descartes, EA 4360 APEMAC, Nancy and Inserm CIC-EC, CHU de Nancy, Nancy, France; Department of Nursing, University of the West of England, Bristol, UK; Swedish Medical Center and University of Washington, Seattle, Washington, USA; Instituto Poal, Barcelona, Spain; SDG LLC, Cambridge, Massachusetts; Birmingham Veterans Affairs Medical Center and University of Alabama at Birmingham, Birmingham, Alabama; Division of Immunology/Rheumatology, Stanford University School of Medicine, Palo Alto, California, USA; Leeds Institute of Rheumatic and Musculoskeletal Medicine, University of Leeds, and UK National Institute for Health Research, Leeds Musculoskeletal Biomedical Research Unit, Leeds, UK; Department of Epidemiology and Community Medicine, and Department of Medicine, University of Ottawa, Ottawa, Ontario, Canada. M-A. D’Agostino, MD, PhD, Versailles-Saint Quentin En Yvelines University, Department of Rheumatology, Ambroise Paré Hospital, APHP; M. Boers, MD, PhD, Departments of Epidemiology and Biostatistics, and Rheumatology, VU University Medical Center; J.R. Kirwan, MD, University of Bristol, Academic Rheumatology Unit, Bristol Royal Infirmary; D.M. van der Heijde, MD, PhD, Department of Rheumatology, Leiden University Medical Center; M. Østergaard, MD, PhD, DMSc, Copenhagen Center for Arthritis Research, Center for Rheumatology and Spine Diseases, Copenhagen University Hospital Glostrup; G. Schett, MD, Department of Internal Medicine 3 and Institute for Clinical Immunology, University of Erlangen-Nuremberg; R.B. Landewé, MD, PhD, Department of Clinical Immunology and Rheumatology, Academic Medical Center, University of Amsterdam and Atrium Medical Center; W.P. Maksymowych, FRCPC, Department of Medicine, University of Alberta; E. Naredo, MD, Department of Rheumatology, Hospital General Universitario Gregorio Marañón; M. Dougados, MD, Paris-Descartes University, Medicine Faculty, APHP, Cochin Hospital, Rheumatology B; A. Iagnocco, MD, Rheumatology Unit, Sapienza Università di Roma; C.O. Bingham III, MD, Division of Rheumatology, Johns Hopkins University; P. Brooks, MD, FRACP, University of Melbourne, Medicine, Dentistry and Health Sciences; D.E. Beaton, BScOT, PhD, Department of Occupational Sciences and Occupational Therapy, Institute for Health Policy Management and Evaluation, University of Toronto; F. Gandjbakhch, MD; Laure Gossec, MD, PhD, UPMC, GRC-UPMC 08 (EEMOIS); AP-HP Pitié Salpêtrière Hospital, Department of Rheumatology; F. Guillemin, MD, PhD, Université de Lorraine, Université Paris Descartes, EA 4360 APEMAC, Nancy and Inserm CIC-EC, CHU de Nancy; S. Hewlett, PhD, RN, Department of Nursing, University of the West of England; M. Kloppenburg, MD, PhD, Department of Rheumatology, Leiden University Medical Center; P.J. Mease, MD, Swedish Medical Center and University of Washington; I. Moller, MD, Instituto Poal; L.S. Simon, MD, SDG LLC; J.A. Singh, MD, MPH, Birmingham Veterans Affairs Medical Center and University of Alabama at Birmingham; V. Strand, MD, Division of Immunology/Rheumatology, Stanford University School of Medicine; R.J. Wakefield BM, MD, FRCP, Leeds Institute of Rheumatic and Musculoskeletal Medicine, University of Leeds, and NIHR, Leeds Musculoskeletal Biomedical Research Unit; G. Wells, Epidemiology and Community Medicine; P. Tugwell, MD, Department of Medicine, University of Ottawa; P.G. Conaghan, MB, BS, PhD, FRACP, FRCP, Leeds Institute of Rheumatic and Musculoskeletal Medicine, University of Leeds, and NIHR, Leeds Musculoskeletal Biomedical Research Unit. Address correspondence to Prof. D’Agostino, Rheumatology Department, APHP Ambroise Paré Hospital, 9 avenue Charles de Gaulle, 92100 Boulogne-Billancourt, France. E-mail: mariaantonietta.dagostino@apr.aphp.fr
Francis Guillemin
From Versailles-Saint Quentin En Yvelines University, Department of Rheumatology, Ambroise Paré Hospital, APHP, Boulogne-Billancourt, France; Departments of Epidemiology and Biostatistics, and Rheumatology, VU University Medical Center, Amsterdam, The Netherlands; University of Bristol, Academic Rheumatology Unit, Bristol Royal Infirmary, Bristol, UK; Department of Rheumatology, Leiden University Medical Center, Leiden, The Netherlands; Copenhagen Center for Arthritis Research, Center for Rheumatology and Spine Diseases, Copenhagen University Hospital Glostrup, Copenhagen, Denmark; Department of Internal Medicine 3 and Institute for Clinical Immunology, University of Erlangen-Nuremberg, Erlangen, Germany; Department of Clinical Immunology and Rheumatology, Academic Medical Center, University of Amsterdam and Atrium Medical Center, Amsterdam, The Netherlands; Department of Medicine, University of Alberta, Edmonton, Alberta, Canada; Department of Rheumatology, Hospital General Universitario Gregorio Marañón, Madrid, Spain; Paris-Descartes University, Medicine Faculty, APHP, Cochin Hospital, Rheumatology B, Paris, France; Rheumatology Unit, Sapienza Università di Roma, Rome, Italy; Division of Rheumatology, Johns Hopkins University, Baltimore, Maryland, USA; University of Melbourne, Medicine, Dentistry and Health Sciences, Melbourne, Australia; St. Michael’s Hospital, Mobility Program Clinical Research Unit; Institute for Work and Health; University of Toronto, Department of Health Policy, Management and Evaluation, Department of Rehabilitation Science and Department of Occupational Science and Occupational Therapy, Toronto, Ontario, Canada; Pierre et Marie Curie University (UPMC) — Paris, GRCUPMC 08 (EEMOIS); AP-HP Pitié Salpêtrière Hospital, Department of Rheumatology, Paris; Université de Lorraine, Université Paris Descartes, EA 4360 APEMAC, Nancy and Inserm CIC-EC, CHU de Nancy, Nancy, France; Department of Nursing, University of the West of England, Bristol, UK; Swedish Medical Center and University of Washington, Seattle, Washington, USA; Instituto Poal, Barcelona, Spain; SDG LLC, Cambridge, Massachusetts; Birmingham Veterans Affairs Medical Center and University of Alabama at Birmingham, Birmingham, Alabama; Division of Immunology/Rheumatology, Stanford University School of Medicine, Palo Alto, California, USA; Leeds Institute of Rheumatic and Musculoskeletal Medicine, University of Leeds, and UK National Institute for Health Research, Leeds Musculoskeletal Biomedical Research Unit, Leeds, UK; Department of Epidemiology and Community Medicine, and Department of Medicine, University of Ottawa, Ottawa, Ontario, Canada. M-A. D’Agostino, MD, PhD, Versailles-Saint Quentin En Yvelines University, Department of Rheumatology, Ambroise Paré Hospital, APHP; M. Boers, MD, PhD, Departments of Epidemiology and Biostatistics, and Rheumatology, VU University Medical Center; J.R. Kirwan, MD, University of Bristol, Academic Rheumatology Unit, Bristol Royal Infirmary; D.M. van der Heijde, MD, PhD, Department of Rheumatology, Leiden University Medical Center; M. Østergaard, MD, PhD, DMSc, Copenhagen Center for Arthritis Research, Center for Rheumatology and Spine Diseases, Copenhagen University Hospital Glostrup; G. Schett, MD, Department of Internal Medicine 3 and Institute for Clinical Immunology, University of Erlangen-Nuremberg; R.B. Landewé, MD, PhD, Department of Clinical Immunology and Rheumatology, Academic Medical Center, University of Amsterdam and Atrium Medical Center; W.P. Maksymowych, FRCPC, Department of Medicine, University of Alberta; E. Naredo, MD, Department of Rheumatology, Hospital General Universitario Gregorio Marañón; M. Dougados, MD, Paris-Descartes University, Medicine Faculty, APHP, Cochin Hospital, Rheumatology B; A. Iagnocco, MD, Rheumatology Unit, Sapienza Università di Roma; C.O. Bingham III, MD, Division of Rheumatology, Johns Hopkins University; P. Brooks, MD, FRACP, University of Melbourne, Medicine, Dentistry and Health Sciences; D.E. Beaton, BScOT, PhD, Department of Occupational Sciences and Occupational Therapy, Institute for Health Policy Management and Evaluation, University of Toronto; F. Gandjbakhch, MD; Laure Gossec, MD, PhD, UPMC, GRC-UPMC 08 (EEMOIS); AP-HP Pitié Salpêtrière Hospital, Department of Rheumatology; F. Guillemin, MD, PhD, Université de Lorraine, Université Paris Descartes, EA 4360 APEMAC, Nancy and Inserm CIC-EC, CHU de Nancy; S. Hewlett, PhD, RN, Department of Nursing, University of the West of England; M. Kloppenburg, MD, PhD, Department of Rheumatology, Leiden University Medical Center; P.J. Mease, MD, Swedish Medical Center and University of Washington; I. Moller, MD, Instituto Poal; L.S. Simon, MD, SDG LLC; J.A. Singh, MD, MPH, Birmingham Veterans Affairs Medical Center and University of Alabama at Birmingham; V. Strand, MD, Division of Immunology/Rheumatology, Stanford University School of Medicine; R.J. Wakefield BM, MD, FRCP, Leeds Institute of Rheumatic and Musculoskeletal Medicine, University of Leeds, and NIHR, Leeds Musculoskeletal Biomedical Research Unit; G. Wells, Epidemiology and Community Medicine; P. Tugwell, MD, Department of Medicine, University of Ottawa; P.G. Conaghan, MB, BS, PhD, FRACP, FRCP, Leeds Institute of Rheumatic and Musculoskeletal Medicine, University of Leeds, and NIHR, Leeds Musculoskeletal Biomedical Research Unit. Address correspondence to Prof. D’Agostino, Rheumatology Department, APHP Ambroise Paré Hospital, 9 avenue Charles de Gaulle, 92100 Boulogne-Billancourt, France. E-mail: mariaantonietta.dagostino@apr.aphp.fr
Sarah E. Hewlett
From Versailles-Saint Quentin En Yvelines University, Department of Rheumatology, Ambroise Paré Hospital, APHP, Boulogne-Billancourt, France; Departments of Epidemiology and Biostatistics, and Rheumatology, VU University Medical Center, Amsterdam, The Netherlands; University of Bristol, Academic Rheumatology Unit, Bristol Royal Infirmary, Bristol, UK; Department of Rheumatology, Leiden University Medical Center, Leiden, The Netherlands; Copenhagen Center for Arthritis Research, Center for Rheumatology and Spine Diseases, Copenhagen University Hospital Glostrup, Copenhagen, Denmark; Department of Internal Medicine 3 and Institute for Clinical Immunology, University of Erlangen-Nuremberg, Erlangen, Germany; Department of Clinical Immunology and Rheumatology, Academic Medical Center, University of Amsterdam and Atrium Medical Center, Amsterdam, The Netherlands; Department of Medicine, University of Alberta, Edmonton, Alberta, Canada; Department of Rheumatology, Hospital General Universitario Gregorio Marañón, Madrid, Spain; Paris-Descartes University, Medicine Faculty, APHP, Cochin Hospital, Rheumatology B, Paris, France; Rheumatology Unit, Sapienza Università di Roma, Rome, Italy; Division of Rheumatology, Johns Hopkins University, Baltimore, Maryland, USA; University of Melbourne, Medicine, Dentistry and Health Sciences, Melbourne, Australia; St. Michael’s Hospital, Mobility Program Clinical Research Unit; Institute for Work and Health; University of Toronto, Department of Health Policy, Management and Evaluation, Department of Rehabilitation Science and Department of Occupational Science and Occupational Therapy, Toronto, Ontario, Canada; Pierre et Marie Curie University (UPMC) — Paris, GRCUPMC 08 (EEMOIS); AP-HP Pitié Salpêtrière Hospital, Department of Rheumatology, Paris; Université de Lorraine, Université Paris Descartes, EA 4360 APEMAC, Nancy and Inserm CIC-EC, CHU de Nancy, Nancy, France; Department of Nursing, University of the West of England, Bristol, UK; Swedish Medical Center and University of Washington, Seattle, Washington, USA; Instituto Poal, Barcelona, Spain; SDG LLC, Cambridge, Massachusetts; Birmingham Veterans Affairs Medical Center and University of Alabama at Birmingham, Birmingham, Alabama; Division of Immunology/Rheumatology, Stanford University School of Medicine, Palo Alto, California, USA; Leeds Institute of Rheumatic and Musculoskeletal Medicine, University of Leeds, and UK National Institute for Health Research, Leeds Musculoskeletal Biomedical Research Unit, Leeds, UK; Department of Epidemiology and Community Medicine, and Department of Medicine, University of Ottawa, Ottawa, Ontario, Canada. M-A. D’Agostino, MD, PhD, Versailles-Saint Quentin En Yvelines University, Department of Rheumatology, Ambroise Paré Hospital, APHP; M. Boers, MD, PhD, Departments of Epidemiology and Biostatistics, and Rheumatology, VU University Medical Center; J.R. Kirwan, MD, University of Bristol, Academic Rheumatology Unit, Bristol Royal Infirmary; D.M. van der Heijde, MD, PhD, Department of Rheumatology, Leiden University Medical Center; M. Østergaard, MD, PhD, DMSc, Copenhagen Center for Arthritis Research, Center for Rheumatology and Spine Diseases, Copenhagen University Hospital Glostrup; G. Schett, MD, Department of Internal Medicine 3 and Institute for Clinical Immunology, University of Erlangen-Nuremberg; R.B. Landewé, MD, PhD, Department of Clinical Immunology and Rheumatology, Academic Medical Center, University of Amsterdam and Atrium Medical Center; W.P. Maksymowych, FRCPC, Department of Medicine, University of Alberta; E. Naredo, MD, Department of Rheumatology, Hospital General Universitario Gregorio Marañón; M. Dougados, MD, Paris-Descartes University, Medicine Faculty, APHP, Cochin Hospital, Rheumatology B; A. Iagnocco, MD, Rheumatology Unit, Sapienza Università di Roma; C.O. Bingham III, MD, Division of Rheumatology, Johns Hopkins University; P. Brooks, MD, FRACP, University of Melbourne, Medicine, Dentistry and Health Sciences; D.E. Beaton, BScOT, PhD, Department of Occupational Sciences and Occupational Therapy, Institute for Health Policy Management and Evaluation, University of Toronto; F. Gandjbakhch, MD; Laure Gossec, MD, PhD, UPMC, GRC-UPMC 08 (EEMOIS); AP-HP Pitié Salpêtrière Hospital, Department of Rheumatology; F. Guillemin, MD, PhD, Université de Lorraine, Université Paris Descartes, EA 4360 APEMAC, Nancy and Inserm CIC-EC, CHU de Nancy; S. Hewlett, PhD, RN, Department of Nursing, University of the West of England; M. Kloppenburg, MD, PhD, Department of Rheumatology, Leiden University Medical Center; P.J. Mease, MD, Swedish Medical Center and University of Washington; I. Moller, MD, Instituto Poal; L.S. Simon, MD, SDG LLC; J.A. Singh, MD, MPH, Birmingham Veterans Affairs Medical Center and University of Alabama at Birmingham; V. Strand, MD, Division of Immunology/Rheumatology, Stanford University School of Medicine; R.J. Wakefield BM, MD, FRCP, Leeds Institute of Rheumatic and Musculoskeletal Medicine, University of Leeds, and NIHR, Leeds Musculoskeletal Biomedical Research Unit; G. Wells, Epidemiology and Community Medicine; P. Tugwell, MD, Department of Medicine, University of Ottawa; P.G. Conaghan, MB, BS, PhD, FRACP, FRCP, Leeds Institute of Rheumatic and Musculoskeletal Medicine, University of Leeds, and NIHR, Leeds Musculoskeletal Biomedical Research Unit. Address correspondence to Prof. D’Agostino, Rheumatology Department, APHP Ambroise Paré Hospital, 9 avenue Charles de Gaulle, 92100 Boulogne-Billancourt, France. E-mail: mariaantonietta.dagostino@apr.aphp.fr
Margreet Kloppenburg
From Versailles-Saint Quentin En Yvelines University, Department of Rheumatology, Ambroise Paré Hospital, APHP, Boulogne-Billancourt, France; Departments of Epidemiology and Biostatistics, and Rheumatology, VU University Medical Center, Amsterdam, The Netherlands; University of Bristol, Academic Rheumatology Unit, Bristol Royal Infirmary, Bristol, UK; Department of Rheumatology, Leiden University Medical Center, Leiden, The Netherlands; Copenhagen Center for Arthritis Research, Center for Rheumatology and Spine Diseases, Copenhagen University Hospital Glostrup, Copenhagen, Denmark; Department of Internal Medicine 3 and Institute for Clinical Immunology, University of Erlangen-Nuremberg, Erlangen, Germany; Department of Clinical Immunology and Rheumatology, Academic Medical Center, University of Amsterdam and Atrium Medical Center, Amsterdam, The Netherlands; Department of Medicine, University of Alberta, Edmonton, Alberta, Canada; Department of Rheumatology, Hospital General Universitario Gregorio Marañón, Madrid, Spain; Paris-Descartes University, Medicine Faculty, APHP, Cochin Hospital, Rheumatology B, Paris, France; Rheumatology Unit, Sapienza Università di Roma, Rome, Italy; Division of Rheumatology, Johns Hopkins University, Baltimore, Maryland, USA; University of Melbourne, Medicine, Dentistry and Health Sciences, Melbourne, Australia; St. Michael’s Hospital, Mobility Program Clinical Research Unit; Institute for Work and Health; University of Toronto, Department of Health Policy, Management and Evaluation, Department of Rehabilitation Science and Department of Occupational Science and Occupational Therapy, Toronto, Ontario, Canada; Pierre et Marie Curie University (UPMC) — Paris, GRCUPMC 08 (EEMOIS); AP-HP Pitié Salpêtrière Hospital, Department of Rheumatology, Paris; Université de Lorraine, Université Paris Descartes, EA 4360 APEMAC, Nancy and Inserm CIC-EC, CHU de Nancy, Nancy, France; Department of Nursing, University of the West of England, Bristol, UK; Swedish Medical Center and University of Washington, Seattle, Washington, USA; Instituto Poal, Barcelona, Spain; SDG LLC, Cambridge, Massachusetts; Birmingham Veterans Affairs Medical Center and University of Alabama at Birmingham, Birmingham, Alabama; Division of Immunology/Rheumatology, Stanford University School of Medicine, Palo Alto, California, USA; Leeds Institute of Rheumatic and Musculoskeletal Medicine, University of Leeds, and UK National Institute for Health Research, Leeds Musculoskeletal Biomedical Research Unit, Leeds, UK; Department of Epidemiology and Community Medicine, and Department of Medicine, University of Ottawa, Ottawa, Ontario, Canada. M-A. D’Agostino, MD, PhD, Versailles-Saint Quentin En Yvelines University, Department of Rheumatology, Ambroise Paré Hospital, APHP; M. Boers, MD, PhD, Departments of Epidemiology and Biostatistics, and Rheumatology, VU University Medical Center; J.R. Kirwan, MD, University of Bristol, Academic Rheumatology Unit, Bristol Royal Infirmary; D.M. van der Heijde, MD, PhD, Department of Rheumatology, Leiden University Medical Center; M. Østergaard, MD, PhD, DMSc, Copenhagen Center for Arthritis Research, Center for Rheumatology and Spine Diseases, Copenhagen University Hospital Glostrup; G. Schett, MD, Department of Internal Medicine 3 and Institute for Clinical Immunology, University of Erlangen-Nuremberg; R.B. Landewé, MD, PhD, Department of Clinical Immunology and Rheumatology, Academic Medical Center, University of Amsterdam and Atrium Medical Center; W.P. Maksymowych, FRCPC, Department of Medicine, University of Alberta; E. Naredo, MD, Department of Rheumatology, Hospital General Universitario Gregorio Marañón; M. Dougados, MD, Paris-Descartes University, Medicine Faculty, APHP, Cochin Hospital, Rheumatology B; A. Iagnocco, MD, Rheumatology Unit, Sapienza Università di Roma; C.O. Bingham III, MD, Division of Rheumatology, Johns Hopkins University; P. Brooks, MD, FRACP, University of Melbourne, Medicine, Dentistry and Health Sciences; D.E. Beaton, BScOT, PhD, Department of Occupational Sciences and Occupational Therapy, Institute for Health Policy Management and Evaluation, University of Toronto; F. Gandjbakhch, MD; Laure Gossec, MD, PhD, UPMC, GRC-UPMC 08 (EEMOIS); AP-HP Pitié Salpêtrière Hospital, Department of Rheumatology; F. Guillemin, MD, PhD, Université de Lorraine, Université Paris Descartes, EA 4360 APEMAC, Nancy and Inserm CIC-EC, CHU de Nancy; S. Hewlett, PhD, RN, Department of Nursing, University of the West of England; M. Kloppenburg, MD, PhD, Department of Rheumatology, Leiden University Medical Center; P.J. Mease, MD, Swedish Medical Center and University of Washington; I. Moller, MD, Instituto Poal; L.S. Simon, MD, SDG LLC; J.A. Singh, MD, MPH, Birmingham Veterans Affairs Medical Center and University of Alabama at Birmingham; V. Strand, MD, Division of Immunology/Rheumatology, Stanford University School of Medicine; R.J. Wakefield BM, MD, FRCP, Leeds Institute of Rheumatic and Musculoskeletal Medicine, University of Leeds, and NIHR, Leeds Musculoskeletal Biomedical Research Unit; G. Wells, Epidemiology and Community Medicine; P. Tugwell, MD, Department of Medicine, University of Ottawa; P.G. Conaghan, MB, BS, PhD, FRACP, FRCP, Leeds Institute of Rheumatic and Musculoskeletal Medicine, University of Leeds, and NIHR, Leeds Musculoskeletal Biomedical Research Unit. Address correspondence to Prof. D’Agostino, Rheumatology Department, APHP Ambroise Paré Hospital, 9 avenue Charles de Gaulle, 92100 Boulogne-Billancourt, France. E-mail: mariaantonietta.dagostino@apr.aphp.fr
Lyn March
From Versailles-Saint Quentin En Yvelines University, Department of Rheumatology, Ambroise Paré Hospital, APHP, Boulogne-Billancourt, France; Departments of Epidemiology and Biostatistics, and Rheumatology, VU University Medical Center, Amsterdam, The Netherlands; University of Bristol, Academic Rheumatology Unit, Bristol Royal Infirmary, Bristol, UK; Department of Rheumatology, Leiden University Medical Center, Leiden, The Netherlands; Copenhagen Center for Arthritis Research, Center for Rheumatology and Spine Diseases, Copenhagen University Hospital Glostrup, Copenhagen, Denmark; Department of Internal Medicine 3 and Institute for Clinical Immunology, University of Erlangen-Nuremberg, Erlangen, Germany; Department of Clinical Immunology and Rheumatology, Academic Medical Center, University of Amsterdam and Atrium Medical Center, Amsterdam, The Netherlands; Department of Medicine, University of Alberta, Edmonton, Alberta, Canada; Department of Rheumatology, Hospital General Universitario Gregorio Marañón, Madrid, Spain; Paris-Descartes University, Medicine Faculty, APHP, Cochin Hospital, Rheumatology B, Paris, France; Rheumatology Unit, Sapienza Università di Roma, Rome, Italy; Division of Rheumatology, Johns Hopkins University, Baltimore, Maryland, USA; University of Melbourne, Medicine, Dentistry and Health Sciences, Melbourne, Australia; St. Michael’s Hospital, Mobility Program Clinical Research Unit; Institute for Work and Health; University of Toronto, Department of Health Policy, Management and Evaluation, Department of Rehabilitation Science and Department of Occupational Science and Occupational Therapy, Toronto, Ontario, Canada; Pierre et Marie Curie University (UPMC) — Paris, GRCUPMC 08 (EEMOIS); AP-HP Pitié Salpêtrière Hospital, Department of Rheumatology, Paris; Université de Lorraine, Université Paris Descartes, EA 4360 APEMAC, Nancy and Inserm CIC-EC, CHU de Nancy, Nancy, France; Department of Nursing, University of the West of England, Bristol, UK; Swedish Medical Center and University of Washington, Seattle, Washington, USA; Instituto Poal, Barcelona, Spain; SDG LLC, Cambridge, Massachusetts; Birmingham Veterans Affairs Medical Center and University of Alabama at Birmingham, Birmingham, Alabama; Division of Immunology/Rheumatology, Stanford University School of Medicine, Palo Alto, California, USA; Leeds Institute of Rheumatic and Musculoskeletal Medicine, University of Leeds, and UK National Institute for Health Research, Leeds Musculoskeletal Biomedical Research Unit, Leeds, UK; Department of Epidemiology and Community Medicine, and Department of Medicine, University of Ottawa, Ottawa, Ontario, Canada. M-A. D’Agostino, MD, PhD, Versailles-Saint Quentin En Yvelines University, Department of Rheumatology, Ambroise Paré Hospital, APHP; M. Boers, MD, PhD, Departments of Epidemiology and Biostatistics, and Rheumatology, VU University Medical Center; J.R. Kirwan, MD, University of Bristol, Academic Rheumatology Unit, Bristol Royal Infirmary; D.M. van der Heijde, MD, PhD, Department of Rheumatology, Leiden University Medical Center; M. Østergaard, MD, PhD, DMSc, Copenhagen Center for Arthritis Research, Center for Rheumatology and Spine Diseases, Copenhagen University Hospital Glostrup; G. Schett, MD, Department of Internal Medicine 3 and Institute for Clinical Immunology, University of Erlangen-Nuremberg; R.B. Landewé, MD, PhD, Department of Clinical Immunology and Rheumatology, Academic Medical Center, University of Amsterdam and Atrium Medical Center; W.P. Maksymowych, FRCPC, Department of Medicine, University of Alberta; E. Naredo, MD, Department of Rheumatology, Hospital General Universitario Gregorio Marañón; M. Dougados, MD, Paris-Descartes University, Medicine Faculty, APHP, Cochin Hospital, Rheumatology B; A. Iagnocco, MD, Rheumatology Unit, Sapienza Università di Roma; C.O. Bingham III, MD, Division of Rheumatology, Johns Hopkins University; P. Brooks, MD, FRACP, University of Melbourne, Medicine, Dentistry and Health Sciences; D.E. Beaton, BScOT, PhD, Department of Occupational Sciences and Occupational Therapy, Institute for Health Policy Management and Evaluation, University of Toronto; F. Gandjbakhch, MD; Laure Gossec, MD, PhD, UPMC, GRC-UPMC 08 (EEMOIS); AP-HP Pitié Salpêtrière Hospital, Department of Rheumatology; F. Guillemin, MD, PhD, Université de Lorraine, Université Paris Descartes, EA 4360 APEMAC, Nancy and Inserm CIC-EC, CHU de Nancy; S. Hewlett, PhD, RN, Department of Nursing, University of the West of England; M. Kloppenburg, MD, PhD, Department of Rheumatology, Leiden University Medical Center; P.J. Mease, MD, Swedish Medical Center and University of Washington; I. Moller, MD, Instituto Poal; L.S. Simon, MD, SDG LLC; J.A. Singh, MD, MPH, Birmingham Veterans Affairs Medical Center and University of Alabama at Birmingham; V. Strand, MD, Division of Immunology/Rheumatology, Stanford University School of Medicine; R.J. Wakefield BM, MD, FRCP, Leeds Institute of Rheumatic and Musculoskeletal Medicine, University of Leeds, and NIHR, Leeds Musculoskeletal Biomedical Research Unit; G. Wells, Epidemiology and Community Medicine; P. Tugwell, MD, Department of Medicine, University of Ottawa; P.G. Conaghan, MB, BS, PhD, FRACP, FRCP, Leeds Institute of Rheumatic and Musculoskeletal Medicine, University of Leeds, and NIHR, Leeds Musculoskeletal Biomedical Research Unit. Address correspondence to Prof. D’Agostino, Rheumatology Department, APHP Ambroise Paré Hospital, 9 avenue Charles de Gaulle, 92100 Boulogne-Billancourt, France. E-mail: mariaantonietta.dagostino@apr.aphp.fr
Philip J. Mease
From Versailles-Saint Quentin En Yvelines University, Department of Rheumatology, Ambroise Paré Hospital, APHP, Boulogne-Billancourt, France; Departments of Epidemiology and Biostatistics, and Rheumatology, VU University Medical Center, Amsterdam, The Netherlands; University of Bristol, Academic Rheumatology Unit, Bristol Royal Infirmary, Bristol, UK; Department of Rheumatology, Leiden University Medical Center, Leiden, The Netherlands; Copenhagen Center for Arthritis Research, Center for Rheumatology and Spine Diseases, Copenhagen University Hospital Glostrup, Copenhagen, Denmark; Department of Internal Medicine 3 and Institute for Clinical Immunology, University of Erlangen-Nuremberg, Erlangen, Germany; Department of Clinical Immunology and Rheumatology, Academic Medical Center, University of Amsterdam and Atrium Medical Center, Amsterdam, The Netherlands; Department of Medicine, University of Alberta, Edmonton, Alberta, Canada; Department of Rheumatology, Hospital General Universitario Gregorio Marañón, Madrid, Spain; Paris-Descartes University, Medicine Faculty, APHP, Cochin Hospital, Rheumatology B, Paris, France; Rheumatology Unit, Sapienza Università di Roma, Rome, Italy; Division of Rheumatology, Johns Hopkins University, Baltimore, Maryland, USA; University of Melbourne, Medicine, Dentistry and Health Sciences, Melbourne, Australia; St. Michael’s Hospital, Mobility Program Clinical Research Unit; Institute for Work and Health; University of Toronto, Department of Health Policy, Management and Evaluation, Department of Rehabilitation Science and Department of Occupational Science and Occupational Therapy, Toronto, Ontario, Canada; Pierre et Marie Curie University (UPMC) — Paris, GRCUPMC 08 (EEMOIS); AP-HP Pitié Salpêtrière Hospital, Department of Rheumatology, Paris; Université de Lorraine, Université Paris Descartes, EA 4360 APEMAC, Nancy and Inserm CIC-EC, CHU de Nancy, Nancy, France; Department of Nursing, University of the West of England, Bristol, UK; Swedish Medical Center and University of Washington, Seattle, Washington, USA; Instituto Poal, Barcelona, Spain; SDG LLC, Cambridge, Massachusetts; Birmingham Veterans Affairs Medical Center and University of Alabama at Birmingham, Birmingham, Alabama; Division of Immunology/Rheumatology, Stanford University School of Medicine, Palo Alto, California, USA; Leeds Institute of Rheumatic and Musculoskeletal Medicine, University of Leeds, and UK National Institute for Health Research, Leeds Musculoskeletal Biomedical Research Unit, Leeds, UK; Department of Epidemiology and Community Medicine, and Department of Medicine, University of Ottawa, Ottawa, Ontario, Canada. M-A. D’Agostino, MD, PhD, Versailles-Saint Quentin En Yvelines University, Department of Rheumatology, Ambroise Paré Hospital, APHP; M. Boers, MD, PhD, Departments of Epidemiology and Biostatistics, and Rheumatology, VU University Medical Center; J.R. Kirwan, MD, University of Bristol, Academic Rheumatology Unit, Bristol Royal Infirmary; D.M. van der Heijde, MD, PhD, Department of Rheumatology, Leiden University Medical Center; M. Østergaard, MD, PhD, DMSc, Copenhagen Center for Arthritis Research, Center for Rheumatology and Spine Diseases, Copenhagen University Hospital Glostrup; G. Schett, MD, Department of Internal Medicine 3 and Institute for Clinical Immunology, University of Erlangen-Nuremberg; R.B. Landewé, MD, PhD, Department of Clinical Immunology and Rheumatology, Academic Medical Center, University of Amsterdam and Atrium Medical Center; W.P. Maksymowych, FRCPC, Department of Medicine, University of Alberta; E. Naredo, MD, Department of Rheumatology, Hospital General Universitario Gregorio Marañón; M. Dougados, MD, Paris-Descartes University, Medicine Faculty, APHP, Cochin Hospital, Rheumatology B; A. Iagnocco, MD, Rheumatology Unit, Sapienza Università di Roma; C.O. Bingham III, MD, Division of Rheumatology, Johns Hopkins University; P. Brooks, MD, FRACP, University of Melbourne, Medicine, Dentistry and Health Sciences; D.E. Beaton, BScOT, PhD, Department of Occupational Sciences and Occupational Therapy, Institute for Health Policy Management and Evaluation, University of Toronto; F. Gandjbakhch, MD; Laure Gossec, MD, PhD, UPMC, GRC-UPMC 08 (EEMOIS); AP-HP Pitié Salpêtrière Hospital, Department of Rheumatology; F. Guillemin, MD, PhD, Université de Lorraine, Université Paris Descartes, EA 4360 APEMAC, Nancy and Inserm CIC-EC, CHU de Nancy; S. Hewlett, PhD, RN, Department of Nursing, University of the West of England; M. Kloppenburg, MD, PhD, Department of Rheumatology, Leiden University Medical Center; P.J. Mease, MD, Swedish Medical Center and University of Washington; I. Moller, MD, Instituto Poal; L.S. Simon, MD, SDG LLC; J.A. Singh, MD, MPH, Birmingham Veterans Affairs Medical Center and University of Alabama at Birmingham; V. Strand, MD, Division of Immunology/Rheumatology, Stanford University School of Medicine; R.J. Wakefield BM, MD, FRCP, Leeds Institute of Rheumatic and Musculoskeletal Medicine, University of Leeds, and NIHR, Leeds Musculoskeletal Biomedical Research Unit; G. Wells, Epidemiology and Community Medicine; P. Tugwell, MD, Department of Medicine, University of Ottawa; P.G. Conaghan, MB, BS, PhD, FRACP, FRCP, Leeds Institute of Rheumatic and Musculoskeletal Medicine, University of Leeds, and NIHR, Leeds Musculoskeletal Biomedical Research Unit. Address correspondence to Prof. D’Agostino, Rheumatology Department, APHP Ambroise Paré Hospital, 9 avenue Charles de Gaulle, 92100 Boulogne-Billancourt, France. E-mail: mariaantonietta.dagostino@apr.aphp.fr
Ingrid Moller
From Versailles-Saint Quentin En Yvelines University, Department of Rheumatology, Ambroise Paré Hospital, APHP, Boulogne-Billancourt, France; Departments of Epidemiology and Biostatistics, and Rheumatology, VU University Medical Center, Amsterdam, The Netherlands; University of Bristol, Academic Rheumatology Unit, Bristol Royal Infirmary, Bristol, UK; Department of Rheumatology, Leiden University Medical Center, Leiden, The Netherlands; Copenhagen Center for Arthritis Research, Center for Rheumatology and Spine Diseases, Copenhagen University Hospital Glostrup, Copenhagen, Denmark; Department of Internal Medicine 3 and Institute for Clinical Immunology, University of Erlangen-Nuremberg, Erlangen, Germany; Department of Clinical Immunology and Rheumatology, Academic Medical Center, University of Amsterdam and Atrium Medical Center, Amsterdam, The Netherlands; Department of Medicine, University of Alberta, Edmonton, Alberta, Canada; Department of Rheumatology, Hospital General Universitario Gregorio Marañón, Madrid, Spain; Paris-Descartes University, Medicine Faculty, APHP, Cochin Hospital, Rheumatology B, Paris, France; Rheumatology Unit, Sapienza Università di Roma, Rome, Italy; Division of Rheumatology, Johns Hopkins University, Baltimore, Maryland, USA; University of Melbourne, Medicine, Dentistry and Health Sciences, Melbourne, Australia; St. Michael’s Hospital, Mobility Program Clinical Research Unit; Institute for Work and Health; University of Toronto, Department of Health Policy, Management and Evaluation, Department of Rehabilitation Science and Department of Occupational Science and Occupational Therapy, Toronto, Ontario, Canada; Pierre et Marie Curie University (UPMC) — Paris, GRCUPMC 08 (EEMOIS); AP-HP Pitié Salpêtrière Hospital, Department of Rheumatology, Paris; Université de Lorraine, Université Paris Descartes, EA 4360 APEMAC, Nancy and Inserm CIC-EC, CHU de Nancy, Nancy, France; Department of Nursing, University of the West of England, Bristol, UK; Swedish Medical Center and University of Washington, Seattle, Washington, USA; Instituto Poal, Barcelona, Spain; SDG LLC, Cambridge, Massachusetts; Birmingham Veterans Affairs Medical Center and University of Alabama at Birmingham, Birmingham, Alabama; Division of Immunology/Rheumatology, Stanford University School of Medicine, Palo Alto, California, USA; Leeds Institute of Rheumatic and Musculoskeletal Medicine, University of Leeds, and UK National Institute for Health Research, Leeds Musculoskeletal Biomedical Research Unit, Leeds, UK; Department of Epidemiology and Community Medicine, and Department of Medicine, University of Ottawa, Ottawa, Ontario, Canada. M-A. D’Agostino, MD, PhD, Versailles-Saint Quentin En Yvelines University, Department of Rheumatology, Ambroise Paré Hospital, APHP; M. Boers, MD, PhD, Departments of Epidemiology and Biostatistics, and Rheumatology, VU University Medical Center; J.R. Kirwan, MD, University of Bristol, Academic Rheumatology Unit, Bristol Royal Infirmary; D.M. van der Heijde, MD, PhD, Department of Rheumatology, Leiden University Medical Center; M. Østergaard, MD, PhD, DMSc, Copenhagen Center for Arthritis Research, Center for Rheumatology and Spine Diseases, Copenhagen University Hospital Glostrup; G. Schett, MD, Department of Internal Medicine 3 and Institute for Clinical Immunology, University of Erlangen-Nuremberg; R.B. Landewé, MD, PhD, Department of Clinical Immunology and Rheumatology, Academic Medical Center, University of Amsterdam and Atrium Medical Center; W.P. Maksymowych, FRCPC, Department of Medicine, University of Alberta; E. Naredo, MD, Department of Rheumatology, Hospital General Universitario Gregorio Marañón; M. Dougados, MD, Paris-Descartes University, Medicine Faculty, APHP, Cochin Hospital, Rheumatology B; A. Iagnocco, MD, Rheumatology Unit, Sapienza Università di Roma; C.O. Bingham III, MD, Division of Rheumatology, Johns Hopkins University; P. Brooks, MD, FRACP, University of Melbourne, Medicine, Dentistry and Health Sciences; D.E. Beaton, BScOT, PhD, Department of Occupational Sciences and Occupational Therapy, Institute for Health Policy Management and Evaluation, University of Toronto; F. Gandjbakhch, MD; Laure Gossec, MD, PhD, UPMC, GRC-UPMC 08 (EEMOIS); AP-HP Pitié Salpêtrière Hospital, Department of Rheumatology; F. Guillemin, MD, PhD, Université de Lorraine, Université Paris Descartes, EA 4360 APEMAC, Nancy and Inserm CIC-EC, CHU de Nancy; S. Hewlett, PhD, RN, Department of Nursing, University of the West of England; M. Kloppenburg, MD, PhD, Department of Rheumatology, Leiden University Medical Center; P.J. Mease, MD, Swedish Medical Center and University of Washington; I. Moller, MD, Instituto Poal; L.S. Simon, MD, SDG LLC; J.A. Singh, MD, MPH, Birmingham Veterans Affairs Medical Center and University of Alabama at Birmingham; V. Strand, MD, Division of Immunology/Rheumatology, Stanford University School of Medicine; R.J. Wakefield BM, MD, FRCP, Leeds Institute of Rheumatic and Musculoskeletal Medicine, University of Leeds, and NIHR, Leeds Musculoskeletal Biomedical Research Unit; G. Wells, Epidemiology and Community Medicine; P. Tugwell, MD, Department of Medicine, University of Ottawa; P.G. Conaghan, MB, BS, PhD, FRACP, FRCP, Leeds Institute of Rheumatic and Musculoskeletal Medicine, University of Leeds, and NIHR, Leeds Musculoskeletal Biomedical Research Unit. Address correspondence to Prof. D’Agostino, Rheumatology Department, APHP Ambroise Paré Hospital, 9 avenue Charles de Gaulle, 92100 Boulogne-Billancourt, France. E-mail: mariaantonietta.dagostino@apr.aphp.fr
Lee S. Simon
From Versailles-Saint Quentin En Yvelines University, Department of Rheumatology, Ambroise Paré Hospital, APHP, Boulogne-Billancourt, France; Departments of Epidemiology and Biostatistics, and Rheumatology, VU University Medical Center, Amsterdam, The Netherlands; University of Bristol, Academic Rheumatology Unit, Bristol Royal Infirmary, Bristol, UK; Department of Rheumatology, Leiden University Medical Center, Leiden, The Netherlands; Copenhagen Center for Arthritis Research, Center for Rheumatology and Spine Diseases, Copenhagen University Hospital Glostrup, Copenhagen, Denmark; Department of Internal Medicine 3 and Institute for Clinical Immunology, University of Erlangen-Nuremberg, Erlangen, Germany; Department of Clinical Immunology and Rheumatology, Academic Medical Center, University of Amsterdam and Atrium Medical Center, Amsterdam, The Netherlands; Department of Medicine, University of Alberta, Edmonton, Alberta, Canada; Department of Rheumatology, Hospital General Universitario Gregorio Marañón, Madrid, Spain; Paris-Descartes University, Medicine Faculty, APHP, Cochin Hospital, Rheumatology B, Paris, France; Rheumatology Unit, Sapienza Università di Roma, Rome, Italy; Division of Rheumatology, Johns Hopkins University, Baltimore, Maryland, USA; University of Melbourne, Medicine, Dentistry and Health Sciences, Melbourne, Australia; St. Michael’s Hospital, Mobility Program Clinical Research Unit; Institute for Work and Health; University of Toronto, Department of Health Policy, Management and Evaluation, Department of Rehabilitation Science and Department of Occupational Science and Occupational Therapy, Toronto, Ontario, Canada; Pierre et Marie Curie University (UPMC) — Paris, GRCUPMC 08 (EEMOIS); AP-HP Pitié Salpêtrière Hospital, Department of Rheumatology, Paris; Université de Lorraine, Université Paris Descartes, EA 4360 APEMAC, Nancy and Inserm CIC-EC, CHU de Nancy, Nancy, France; Department of Nursing, University of the West of England, Bristol, UK; Swedish Medical Center and University of Washington, Seattle, Washington, USA; Instituto Poal, Barcelona, Spain; SDG LLC, Cambridge, Massachusetts; Birmingham Veterans Affairs Medical Center and University of Alabama at Birmingham, Birmingham, Alabama; Division of Immunology/Rheumatology, Stanford University School of Medicine, Palo Alto, California, USA; Leeds Institute of Rheumatic and Musculoskeletal Medicine, University of Leeds, and UK National Institute for Health Research, Leeds Musculoskeletal Biomedical Research Unit, Leeds, UK; Department of Epidemiology and Community Medicine, and Department of Medicine, University of Ottawa, Ottawa, Ontario, Canada. M-A. D’Agostino, MD, PhD, Versailles-Saint Quentin En Yvelines University, Department of Rheumatology, Ambroise Paré Hospital, APHP; M. Boers, MD, PhD, Departments of Epidemiology and Biostatistics, and Rheumatology, VU University Medical Center; J.R. Kirwan, MD, University of Bristol, Academic Rheumatology Unit, Bristol Royal Infirmary; D.M. van der Heijde, MD, PhD, Department of Rheumatology, Leiden University Medical Center; M. Østergaard, MD, PhD, DMSc, Copenhagen Center for Arthritis Research, Center for Rheumatology and Spine Diseases, Copenhagen University Hospital Glostrup; G. Schett, MD, Department of Internal Medicine 3 and Institute for Clinical Immunology, University of Erlangen-Nuremberg; R.B. Landewé, MD, PhD, Department of Clinical Immunology and Rheumatology, Academic Medical Center, University of Amsterdam and Atrium Medical Center; W.P. Maksymowych, FRCPC, Department of Medicine, University of Alberta; E. Naredo, MD, Department of Rheumatology, Hospital General Universitario Gregorio Marañón; M. Dougados, MD, Paris-Descartes University, Medicine Faculty, APHP, Cochin Hospital, Rheumatology B; A. Iagnocco, MD, Rheumatology Unit, Sapienza Università di Roma; C.O. Bingham III, MD, Division of Rheumatology, Johns Hopkins University; P. Brooks, MD, FRACP, University of Melbourne, Medicine, Dentistry and Health Sciences; D.E. Beaton, BScOT, PhD, Department of Occupational Sciences and Occupational Therapy, Institute for Health Policy Management and Evaluation, University of Toronto; F. Gandjbakhch, MD; Laure Gossec, MD, PhD, UPMC, GRC-UPMC 08 (EEMOIS); AP-HP Pitié Salpêtrière Hospital, Department of Rheumatology; F. Guillemin, MD, PhD, Université de Lorraine, Université Paris Descartes, EA 4360 APEMAC, Nancy and Inserm CIC-EC, CHU de Nancy; S. Hewlett, PhD, RN, Department of Nursing, University of the West of England; M. Kloppenburg, MD, PhD, Department of Rheumatology, Leiden University Medical Center; P.J. Mease, MD, Swedish Medical Center and University of Washington; I. Moller, MD, Instituto Poal; L.S. Simon, MD, SDG LLC; J.A. Singh, MD, MPH, Birmingham Veterans Affairs Medical Center and University of Alabama at Birmingham; V. Strand, MD, Division of Immunology/Rheumatology, Stanford University School of Medicine; R.J. Wakefield BM, MD, FRCP, Leeds Institute of Rheumatic and Musculoskeletal Medicine, University of Leeds, and NIHR, Leeds Musculoskeletal Biomedical Research Unit; G. Wells, Epidemiology and Community Medicine; P. Tugwell, MD, Department of Medicine, University of Ottawa; P.G. Conaghan, MB, BS, PhD, FRACP, FRCP, Leeds Institute of Rheumatic and Musculoskeletal Medicine, University of Leeds, and NIHR, Leeds Musculoskeletal Biomedical Research Unit. Address correspondence to Prof. D’Agostino, Rheumatology Department, APHP Ambroise Paré Hospital, 9 avenue Charles de Gaulle, 92100 Boulogne-Billancourt, France. E-mail: mariaantonietta.dagostino@apr.aphp.fr
Jasvinder A. Singh
From Versailles-Saint Quentin En Yvelines University, Department of Rheumatology, Ambroise Paré Hospital, APHP, Boulogne-Billancourt, France; Departments of Epidemiology and Biostatistics, and Rheumatology, VU University Medical Center, Amsterdam, The Netherlands; University of Bristol, Academic Rheumatology Unit, Bristol Royal Infirmary, Bristol, UK; Department of Rheumatology, Leiden University Medical Center, Leiden, The Netherlands; Copenhagen Center for Arthritis Research, Center for Rheumatology and Spine Diseases, Copenhagen University Hospital Glostrup, Copenhagen, Denmark; Department of Internal Medicine 3 and Institute for Clinical Immunology, University of Erlangen-Nuremberg, Erlangen, Germany; Department of Clinical Immunology and Rheumatology, Academic Medical Center, University of Amsterdam and Atrium Medical Center, Amsterdam, The Netherlands; Department of Medicine, University of Alberta, Edmonton, Alberta, Canada; Department of Rheumatology, Hospital General Universitario Gregorio Marañón, Madrid, Spain; Paris-Descartes University, Medicine Faculty, APHP, Cochin Hospital, Rheumatology B, Paris, France; Rheumatology Unit, Sapienza Università di Roma, Rome, Italy; Division of Rheumatology, Johns Hopkins University, Baltimore, Maryland, USA; University of Melbourne, Medicine, Dentistry and Health Sciences, Melbourne, Australia; St. Michael’s Hospital, Mobility Program Clinical Research Unit; Institute for Work and Health; University of Toronto, Department of Health Policy, Management and Evaluation, Department of Rehabilitation Science and Department of Occupational Science and Occupational Therapy, Toronto, Ontario, Canada; Pierre et Marie Curie University (UPMC) — Paris, GRCUPMC 08 (EEMOIS); AP-HP Pitié Salpêtrière Hospital, Department of Rheumatology, Paris; Université de Lorraine, Université Paris Descartes, EA 4360 APEMAC, Nancy and Inserm CIC-EC, CHU de Nancy, Nancy, France; Department of Nursing, University of the West of England, Bristol, UK; Swedish Medical Center and University of Washington, Seattle, Washington, USA; Instituto Poal, Barcelona, Spain; SDG LLC, Cambridge, Massachusetts; Birmingham Veterans Affairs Medical Center and University of Alabama at Birmingham, Birmingham, Alabama; Division of Immunology/Rheumatology, Stanford University School of Medicine, Palo Alto, California, USA; Leeds Institute of Rheumatic and Musculoskeletal Medicine, University of Leeds, and UK National Institute for Health Research, Leeds Musculoskeletal Biomedical Research Unit, Leeds, UK; Department of Epidemiology and Community Medicine, and Department of Medicine, University of Ottawa, Ottawa, Ontario, Canada. M-A. D’Agostino, MD, PhD, Versailles-Saint Quentin En Yvelines University, Department of Rheumatology, Ambroise Paré Hospital, APHP; M. Boers, MD, PhD, Departments of Epidemiology and Biostatistics, and Rheumatology, VU University Medical Center; J.R. Kirwan, MD, University of Bristol, Academic Rheumatology Unit, Bristol Royal Infirmary; D.M. van der Heijde, MD, PhD, Department of Rheumatology, Leiden University Medical Center; M. Østergaard, MD, PhD, DMSc, Copenhagen Center for Arthritis Research, Center for Rheumatology and Spine Diseases, Copenhagen University Hospital Glostrup; G. Schett, MD, Department of Internal Medicine 3 and Institute for Clinical Immunology, University of Erlangen-Nuremberg; R.B. Landewé, MD, PhD, Department of Clinical Immunology and Rheumatology, Academic Medical Center, University of Amsterdam and Atrium Medical Center; W.P. Maksymowych, FRCPC, Department of Medicine, University of Alberta; E. Naredo, MD, Department of Rheumatology, Hospital General Universitario Gregorio Marañón; M. Dougados, MD, Paris-Descartes University, Medicine Faculty, APHP, Cochin Hospital, Rheumatology B; A. Iagnocco, MD, Rheumatology Unit, Sapienza Università di Roma; C.O. Bingham III, MD, Division of Rheumatology, Johns Hopkins University; P. Brooks, MD, FRACP, University of Melbourne, Medicine, Dentistry and Health Sciences; D.E. Beaton, BScOT, PhD, Department of Occupational Sciences and Occupational Therapy, Institute for Health Policy Management and Evaluation, University of Toronto; F. Gandjbakhch, MD; Laure Gossec, MD, PhD, UPMC, GRC-UPMC 08 (EEMOIS); AP-HP Pitié Salpêtrière Hospital, Department of Rheumatology; F. Guillemin, MD, PhD, Université de Lorraine, Université Paris Descartes, EA 4360 APEMAC, Nancy and Inserm CIC-EC, CHU de Nancy; S. Hewlett, PhD, RN, Department of Nursing, University of the West of England; M. Kloppenburg, MD, PhD, Department of Rheumatology, Leiden University Medical Center; P.J. Mease, MD, Swedish Medical Center and University of Washington; I. Moller, MD, Instituto Poal; L.S. Simon, MD, SDG LLC; J.A. Singh, MD, MPH, Birmingham Veterans Affairs Medical Center and University of Alabama at Birmingham; V. Strand, MD, Division of Immunology/Rheumatology, Stanford University School of Medicine; R.J. Wakefield BM, MD, FRCP, Leeds Institute of Rheumatic and Musculoskeletal Medicine, University of Leeds, and NIHR, Leeds Musculoskeletal Biomedical Research Unit; G. Wells, Epidemiology and Community Medicine; P. Tugwell, MD, Department of Medicine, University of Ottawa; P.G. Conaghan, MB, BS, PhD, FRACP, FRCP, Leeds Institute of Rheumatic and Musculoskeletal Medicine, University of Leeds, and NIHR, Leeds Musculoskeletal Biomedical Research Unit. Address correspondence to Prof. D’Agostino, Rheumatology Department, APHP Ambroise Paré Hospital, 9 avenue Charles de Gaulle, 92100 Boulogne-Billancourt, France. E-mail: mariaantonietta.dagostino@apr.aphp.fr
Vibeke Strand
From Versailles-Saint Quentin En Yvelines University, Department of Rheumatology, Ambroise Paré Hospital, APHP, Boulogne-Billancourt, France; Departments of Epidemiology and Biostatistics, and Rheumatology, VU University Medical Center, Amsterdam, The Netherlands; University of Bristol, Academic Rheumatology Unit, Bristol Royal Infirmary, Bristol, UK; Department of Rheumatology, Leiden University Medical Center, Leiden, The Netherlands; Copenhagen Center for Arthritis Research, Center for Rheumatology and Spine Diseases, Copenhagen University Hospital Glostrup, Copenhagen, Denmark; Department of Internal Medicine 3 and Institute for Clinical Immunology, University of Erlangen-Nuremberg, Erlangen, Germany; Department of Clinical Immunology and Rheumatology, Academic Medical Center, University of Amsterdam and Atrium Medical Center, Amsterdam, The Netherlands; Department of Medicine, University of Alberta, Edmonton, Alberta, Canada; Department of Rheumatology, Hospital General Universitario Gregorio Marañón, Madrid, Spain; Paris-Descartes University, Medicine Faculty, APHP, Cochin Hospital, Rheumatology B, Paris, France; Rheumatology Unit, Sapienza Università di Roma, Rome, Italy; Division of Rheumatology, Johns Hopkins University, Baltimore, Maryland, USA; University of Melbourne, Medicine, Dentistry and Health Sciences, Melbourne, Australia; St. Michael’s Hospital, Mobility Program Clinical Research Unit; Institute for Work and Health; University of Toronto, Department of Health Policy, Management and Evaluation, Department of Rehabilitation Science and Department of Occupational Science and Occupational Therapy, Toronto, Ontario, Canada; Pierre et Marie Curie University (UPMC) — Paris, GRCUPMC 08 (EEMOIS); AP-HP Pitié Salpêtrière Hospital, Department of Rheumatology, Paris; Université de Lorraine, Université Paris Descartes, EA 4360 APEMAC, Nancy and Inserm CIC-EC, CHU de Nancy, Nancy, France; Department of Nursing, University of the West of England, Bristol, UK; Swedish Medical Center and University of Washington, Seattle, Washington, USA; Instituto Poal, Barcelona, Spain; SDG LLC, Cambridge, Massachusetts; Birmingham Veterans Affairs Medical Center and University of Alabama at Birmingham, Birmingham, Alabama; Division of Immunology/Rheumatology, Stanford University School of Medicine, Palo Alto, California, USA; Leeds Institute of Rheumatic and Musculoskeletal Medicine, University of Leeds, and UK National Institute for Health Research, Leeds Musculoskeletal Biomedical Research Unit, Leeds, UK; Department of Epidemiology and Community Medicine, and Department of Medicine, University of Ottawa, Ottawa, Ontario, Canada. M-A. D’Agostino, MD, PhD, Versailles-Saint Quentin En Yvelines University, Department of Rheumatology, Ambroise Paré Hospital, APHP; M. Boers, MD, PhD, Departments of Epidemiology and Biostatistics, and Rheumatology, VU University Medical Center; J.R. Kirwan, MD, University of Bristol, Academic Rheumatology Unit, Bristol Royal Infirmary; D.M. van der Heijde, MD, PhD, Department of Rheumatology, Leiden University Medical Center; M. Østergaard, MD, PhD, DMSc, Copenhagen Center for Arthritis Research, Center for Rheumatology and Spine Diseases, Copenhagen University Hospital Glostrup; G. Schett, MD, Department of Internal Medicine 3 and Institute for Clinical Immunology, University of Erlangen-Nuremberg; R.B. Landewé, MD, PhD, Department of Clinical Immunology and Rheumatology, Academic Medical Center, University of Amsterdam and Atrium Medical Center; W.P. Maksymowych, FRCPC, Department of Medicine, University of Alberta; E. Naredo, MD, Department of Rheumatology, Hospital General Universitario Gregorio Marañón; M. Dougados, MD, Paris-Descartes University, Medicine Faculty, APHP, Cochin Hospital, Rheumatology B; A. Iagnocco, MD, Rheumatology Unit, Sapienza Università di Roma; C.O. Bingham III, MD, Division of Rheumatology, Johns Hopkins University; P. Brooks, MD, FRACP, University of Melbourne, Medicine, Dentistry and Health Sciences; D.E. Beaton, BScOT, PhD, Department of Occupational Sciences and Occupational Therapy, Institute for Health Policy Management and Evaluation, University of Toronto; F. Gandjbakhch, MD; Laure Gossec, MD, PhD, UPMC, GRC-UPMC 08 (EEMOIS); AP-HP Pitié Salpêtrière Hospital, Department of Rheumatology; F. Guillemin, MD, PhD, Université de Lorraine, Université Paris Descartes, EA 4360 APEMAC, Nancy and Inserm CIC-EC, CHU de Nancy; S. Hewlett, PhD, RN, Department of Nursing, University of the West of England; M. Kloppenburg, MD, PhD, Department of Rheumatology, Leiden University Medical Center; P.J. Mease, MD, Swedish Medical Center and University of Washington; I. Moller, MD, Instituto Poal; L.S. Simon, MD, SDG LLC; J.A. Singh, MD, MPH, Birmingham Veterans Affairs Medical Center and University of Alabama at Birmingham; V. Strand, MD, Division of Immunology/Rheumatology, Stanford University School of Medicine; R.J. Wakefield BM, MD, FRCP, Leeds Institute of Rheumatic and Musculoskeletal Medicine, University of Leeds, and NIHR, Leeds Musculoskeletal Biomedical Research Unit; G. Wells, Epidemiology and Community Medicine; P. Tugwell, MD, Department of Medicine, University of Ottawa; P.G. Conaghan, MB, BS, PhD, FRACP, FRCP, Leeds Institute of Rheumatic and Musculoskeletal Medicine, University of Leeds, and NIHR, Leeds Musculoskeletal Biomedical Research Unit. Address correspondence to Prof. D’Agostino, Rheumatology Department, APHP Ambroise Paré Hospital, 9 avenue Charles de Gaulle, 92100 Boulogne-Billancourt, France. E-mail: mariaantonietta.dagostino@apr.aphp.fr
Richard J. Wakefield
From Versailles-Saint Quentin En Yvelines University, Department of Rheumatology, Ambroise Paré Hospital, APHP, Boulogne-Billancourt, France; Departments of Epidemiology and Biostatistics, and Rheumatology, VU University Medical Center, Amsterdam, The Netherlands; University of Bristol, Academic Rheumatology Unit, Bristol Royal Infirmary, Bristol, UK; Department of Rheumatology, Leiden University Medical Center, Leiden, The Netherlands; Copenhagen Center for Arthritis Research, Center for Rheumatology and Spine Diseases, Copenhagen University Hospital Glostrup, Copenhagen, Denmark; Department of Internal Medicine 3 and Institute for Clinical Immunology, University of Erlangen-Nuremberg, Erlangen, Germany; Department of Clinical Immunology and Rheumatology, Academic Medical Center, University of Amsterdam and Atrium Medical Center, Amsterdam, The Netherlands; Department of Medicine, University of Alberta, Edmonton, Alberta, Canada; Department of Rheumatology, Hospital General Universitario Gregorio Marañón, Madrid, Spain; Paris-Descartes University, Medicine Faculty, APHP, Cochin Hospital, Rheumatology B, Paris, France; Rheumatology Unit, Sapienza Università di Roma, Rome, Italy; Division of Rheumatology, Johns Hopkins University, Baltimore, Maryland, USA; University of Melbourne, Medicine, Dentistry and Health Sciences, Melbourne, Australia; St. Michael’s Hospital, Mobility Program Clinical Research Unit; Institute for Work and Health; University of Toronto, Department of Health Policy, Management and Evaluation, Department of Rehabilitation Science and Department of Occupational Science and Occupational Therapy, Toronto, Ontario, Canada; Pierre et Marie Curie University (UPMC) — Paris, GRCUPMC 08 (EEMOIS); AP-HP Pitié Salpêtrière Hospital, Department of Rheumatology, Paris; Université de Lorraine, Université Paris Descartes, EA 4360 APEMAC, Nancy and Inserm CIC-EC, CHU de Nancy, Nancy, France; Department of Nursing, University of the West of England, Bristol, UK; Swedish Medical Center and University of Washington, Seattle, Washington, USA; Instituto Poal, Barcelona, Spain; SDG LLC, Cambridge, Massachusetts; Birmingham Veterans Affairs Medical Center and University of Alabama at Birmingham, Birmingham, Alabama; Division of Immunology/Rheumatology, Stanford University School of Medicine, Palo Alto, California, USA; Leeds Institute of Rheumatic and Musculoskeletal Medicine, University of Leeds, and UK National Institute for Health Research, Leeds Musculoskeletal Biomedical Research Unit, Leeds, UK; Department of Epidemiology and Community Medicine, and Department of Medicine, University of Ottawa, Ottawa, Ontario, Canada. M-A. D’Agostino, MD, PhD, Versailles-Saint Quentin En Yvelines University, Department of Rheumatology, Ambroise Paré Hospital, APHP; M. Boers, MD, PhD, Departments of Epidemiology and Biostatistics, and Rheumatology, VU University Medical Center; J.R. Kirwan, MD, University of Bristol, Academic Rheumatology Unit, Bristol Royal Infirmary; D.M. van der Heijde, MD, PhD, Department of Rheumatology, Leiden University Medical Center; M. Østergaard, MD, PhD, DMSc, Copenhagen Center for Arthritis Research, Center for Rheumatology and Spine Diseases, Copenhagen University Hospital Glostrup; G. Schett, MD, Department of Internal Medicine 3 and Institute for Clinical Immunology, University of Erlangen-Nuremberg; R.B. Landewé, MD, PhD, Department of Clinical Immunology and Rheumatology, Academic Medical Center, University of Amsterdam and Atrium Medical Center; W.P. Maksymowych, FRCPC, Department of Medicine, University of Alberta; E. Naredo, MD, Department of Rheumatology, Hospital General Universitario Gregorio Marañón; M. Dougados, MD, Paris-Descartes University, Medicine Faculty, APHP, Cochin Hospital, Rheumatology B; A. Iagnocco, MD, Rheumatology Unit, Sapienza Università di Roma; C.O. Bingham III, MD, Division of Rheumatology, Johns Hopkins University; P. Brooks, MD, FRACP, University of Melbourne, Medicine, Dentistry and Health Sciences; D.E. Beaton, BScOT, PhD, Department of Occupational Sciences and Occupational Therapy, Institute for Health Policy Management and Evaluation, University of Toronto; F. Gandjbakhch, MD; Laure Gossec, MD, PhD, UPMC, GRC-UPMC 08 (EEMOIS); AP-HP Pitié Salpêtrière Hospital, Department of Rheumatology; F. Guillemin, MD, PhD, Université de Lorraine, Université Paris Descartes, EA 4360 APEMAC, Nancy and Inserm CIC-EC, CHU de Nancy; S. Hewlett, PhD, RN, Department of Nursing, University of the West of England; M. Kloppenburg, MD, PhD, Department of Rheumatology, Leiden University Medical Center; P.J. Mease, MD, Swedish Medical Center and University of Washington; I. Moller, MD, Instituto Poal; L.S. Simon, MD, SDG LLC; J.A. Singh, MD, MPH, Birmingham Veterans Affairs Medical Center and University of Alabama at Birmingham; V. Strand, MD, Division of Immunology/Rheumatology, Stanford University School of Medicine; R.J. Wakefield BM, MD, FRCP, Leeds Institute of Rheumatic and Musculoskeletal Medicine, University of Leeds, and NIHR, Leeds Musculoskeletal Biomedical Research Unit; G. Wells, Epidemiology and Community Medicine; P. Tugwell, MD, Department of Medicine, University of Ottawa; P.G. Conaghan, MB, BS, PhD, FRACP, FRCP, Leeds Institute of Rheumatic and Musculoskeletal Medicine, University of Leeds, and NIHR, Leeds Musculoskeletal Biomedical Research Unit. Address correspondence to Prof. D’Agostino, Rheumatology Department, APHP Ambroise Paré Hospital, 9 avenue Charles de Gaulle, 92100 Boulogne-Billancourt, France. E-mail: mariaantonietta.dagostino@apr.aphp.fr
George A. Wells
From Versailles-Saint Quentin En Yvelines University, Department of Rheumatology, Ambroise Paré Hospital, APHP, Boulogne-Billancourt, France; Departments of Epidemiology and Biostatistics, and Rheumatology, VU University Medical Center, Amsterdam, The Netherlands; University of Bristol, Academic Rheumatology Unit, Bristol Royal Infirmary, Bristol, UK; Department of Rheumatology, Leiden University Medical Center, Leiden, The Netherlands; Copenhagen Center for Arthritis Research, Center for Rheumatology and Spine Diseases, Copenhagen University Hospital Glostrup, Copenhagen, Denmark; Department of Internal Medicine 3 and Institute for Clinical Immunology, University of Erlangen-Nuremberg, Erlangen, Germany; Department of Clinical Immunology and Rheumatology, Academic Medical Center, University of Amsterdam and Atrium Medical Center, Amsterdam, The Netherlands; Department of Medicine, University of Alberta, Edmonton, Alberta, Canada; Department of Rheumatology, Hospital General Universitario Gregorio Marañón, Madrid, Spain; Paris-Descartes University, Medicine Faculty, APHP, Cochin Hospital, Rheumatology B, Paris, France; Rheumatology Unit, Sapienza Università di Roma, Rome, Italy; Division of Rheumatology, Johns Hopkins University, Baltimore, Maryland, USA; University of Melbourne, Medicine, Dentistry and Health Sciences, Melbourne, Australia; St. Michael’s Hospital, Mobility Program Clinical Research Unit; Institute for Work and Health; University of Toronto, Department of Health Policy, Management and Evaluation, Department of Rehabilitation Science and Department of Occupational Science and Occupational Therapy, Toronto, Ontario, Canada; Pierre et Marie Curie University (UPMC) — Paris, GRCUPMC 08 (EEMOIS); AP-HP Pitié Salpêtrière Hospital, Department of Rheumatology, Paris; Université de Lorraine, Université Paris Descartes, EA 4360 APEMAC, Nancy and Inserm CIC-EC, CHU de Nancy, Nancy, France; Department of Nursing, University of the West of England, Bristol, UK; Swedish Medical Center and University of Washington, Seattle, Washington, USA; Instituto Poal, Barcelona, Spain; SDG LLC, Cambridge, Massachusetts; Birmingham Veterans Affairs Medical Center and University of Alabama at Birmingham, Birmingham, Alabama; Division of Immunology/Rheumatology, Stanford University School of Medicine, Palo Alto, California, USA; Leeds Institute of Rheumatic and Musculoskeletal Medicine, University of Leeds, and UK National Institute for Health Research, Leeds Musculoskeletal Biomedical Research Unit, Leeds, UK; Department of Epidemiology and Community Medicine, and Department of Medicine, University of Ottawa, Ottawa, Ontario, Canada. M-A. D’Agostino, MD, PhD, Versailles-Saint Quentin En Yvelines University, Department of Rheumatology, Ambroise Paré Hospital, APHP; M. Boers, MD, PhD, Departments of Epidemiology and Biostatistics, and Rheumatology, VU University Medical Center; J.R. Kirwan, MD, University of Bristol, Academic Rheumatology Unit, Bristol Royal Infirmary; D.M. van der Heijde, MD, PhD, Department of Rheumatology, Leiden University Medical Center; M. Østergaard, MD, PhD, DMSc, Copenhagen Center for Arthritis Research, Center for Rheumatology and Spine Diseases, Copenhagen University Hospital Glostrup; G. Schett, MD, Department of Internal Medicine 3 and Institute for Clinical Immunology, University of Erlangen-Nuremberg; R.B. Landewé, MD, PhD, Department of Clinical Immunology and Rheumatology, Academic Medical Center, University of Amsterdam and Atrium Medical Center; W.P. Maksymowych, FRCPC, Department of Medicine, University of Alberta; E. Naredo, MD, Department of Rheumatology, Hospital General Universitario Gregorio Marañón; M. Dougados, MD, Paris-Descartes University, Medicine Faculty, APHP, Cochin Hospital, Rheumatology B; A. Iagnocco, MD, Rheumatology Unit, Sapienza Università di Roma; C.O. Bingham III, MD, Division of Rheumatology, Johns Hopkins University; P. Brooks, MD, FRACP, University of Melbourne, Medicine, Dentistry and Health Sciences; D.E. Beaton, BScOT, PhD, Department of Occupational Sciences and Occupational Therapy, Institute for Health Policy Management and Evaluation, University of Toronto; F. Gandjbakhch, MD; Laure Gossec, MD, PhD, UPMC, GRC-UPMC 08 (EEMOIS); AP-HP Pitié Salpêtrière Hospital, Department of Rheumatology; F. Guillemin, MD, PhD, Université de Lorraine, Université Paris Descartes, EA 4360 APEMAC, Nancy and Inserm CIC-EC, CHU de Nancy; S. Hewlett, PhD, RN, Department of Nursing, University of the West of England; M. Kloppenburg, MD, PhD, Department of Rheumatology, Leiden University Medical Center; P.J. Mease, MD, Swedish Medical Center and University of Washington; I. Moller, MD, Instituto Poal; L.S. Simon, MD, SDG LLC; J.A. Singh, MD, MPH, Birmingham Veterans Affairs Medical Center and University of Alabama at Birmingham; V. Strand, MD, Division of Immunology/Rheumatology, Stanford University School of Medicine; R.J. Wakefield BM, MD, FRCP, Leeds Institute of Rheumatic and Musculoskeletal Medicine, University of Leeds, and NIHR, Leeds Musculoskeletal Biomedical Research Unit; G. Wells, Epidemiology and Community Medicine; P. Tugwell, MD, Department of Medicine, University of Ottawa; P.G. Conaghan, MB, BS, PhD, FRACP, FRCP, Leeds Institute of Rheumatic and Musculoskeletal Medicine, University of Leeds, and NIHR, Leeds Musculoskeletal Biomedical Research Unit. Address correspondence to Prof. D’Agostino, Rheumatology Department, APHP Ambroise Paré Hospital, 9 avenue Charles de Gaulle, 92100 Boulogne-Billancourt, France. E-mail: mariaantonietta.dagostino@apr.aphp.fr
Peter Tugwell
From Versailles-Saint Quentin En Yvelines University, Department of Rheumatology, Ambroise Paré Hospital, APHP, Boulogne-Billancourt, France; Departments of Epidemiology and Biostatistics, and Rheumatology, VU University Medical Center, Amsterdam, The Netherlands; University of Bristol, Academic Rheumatology Unit, Bristol Royal Infirmary, Bristol, UK; Department of Rheumatology, Leiden University Medical Center, Leiden, The Netherlands; Copenhagen Center for Arthritis Research, Center for Rheumatology and Spine Diseases, Copenhagen University Hospital Glostrup, Copenhagen, Denmark; Department of Internal Medicine 3 and Institute for Clinical Immunology, University of Erlangen-Nuremberg, Erlangen, Germany; Department of Clinical Immunology and Rheumatology, Academic Medical Center, University of Amsterdam and Atrium Medical Center, Amsterdam, The Netherlands; Department of Medicine, University of Alberta, Edmonton, Alberta, Canada; Department of Rheumatology, Hospital General Universitario Gregorio Marañón, Madrid, Spain; Paris-Descartes University, Medicine Faculty, APHP, Cochin Hospital, Rheumatology B, Paris, France; Rheumatology Unit, Sapienza Università di Roma, Rome, Italy; Division of Rheumatology, Johns Hopkins University, Baltimore, Maryland, USA; University of Melbourne, Medicine, Dentistry and Health Sciences, Melbourne, Australia; St. Michael’s Hospital, Mobility Program Clinical Research Unit; Institute for Work and Health; University of Toronto, Department of Health Policy, Management and Evaluation, Department of Rehabilitation Science and Department of Occupational Science and Occupational Therapy, Toronto, Ontario, Canada; Pierre et Marie Curie University (UPMC) — Paris, GRCUPMC 08 (EEMOIS); AP-HP Pitié Salpêtrière Hospital, Department of Rheumatology, Paris; Université de Lorraine, Université Paris Descartes, EA 4360 APEMAC, Nancy and Inserm CIC-EC, CHU de Nancy, Nancy, France; Department of Nursing, University of the West of England, Bristol, UK; Swedish Medical Center and University of Washington, Seattle, Washington, USA; Instituto Poal, Barcelona, Spain; SDG LLC, Cambridge, Massachusetts; Birmingham Veterans Affairs Medical Center and University of Alabama at Birmingham, Birmingham, Alabama; Division of Immunology/Rheumatology, Stanford University School of Medicine, Palo Alto, California, USA; Leeds Institute of Rheumatic and Musculoskeletal Medicine, University of Leeds, and UK National Institute for Health Research, Leeds Musculoskeletal Biomedical Research Unit, Leeds, UK; Department of Epidemiology and Community Medicine, and Department of Medicine, University of Ottawa, Ottawa, Ontario, Canada. M-A. D’Agostino, MD, PhD, Versailles-Saint Quentin En Yvelines University, Department of Rheumatology, Ambroise Paré Hospital, APHP; M. Boers, MD, PhD, Departments of Epidemiology and Biostatistics, and Rheumatology, VU University Medical Center; J.R. Kirwan, MD, University of Bristol, Academic Rheumatology Unit, Bristol Royal Infirmary; D.M. van der Heijde, MD, PhD, Department of Rheumatology, Leiden University Medical Center; M. Østergaard, MD, PhD, DMSc, Copenhagen Center for Arthritis Research, Center for Rheumatology and Spine Diseases, Copenhagen University Hospital Glostrup; G. Schett, MD, Department of Internal Medicine 3 and Institute for Clinical Immunology, University of Erlangen-Nuremberg; R.B. Landewé, MD, PhD, Department of Clinical Immunology and Rheumatology, Academic Medical Center, University of Amsterdam and Atrium Medical Center; W.P. Maksymowych, FRCPC, Department of Medicine, University of Alberta; E. Naredo, MD, Department of Rheumatology, Hospital General Universitario Gregorio Marañón; M. Dougados, MD, Paris-Descartes University, Medicine Faculty, APHP, Cochin Hospital, Rheumatology B; A. Iagnocco, MD, Rheumatology Unit, Sapienza Università di Roma; C.O. Bingham III, MD, Division of Rheumatology, Johns Hopkins University; P. Brooks, MD, FRACP, University of Melbourne, Medicine, Dentistry and Health Sciences; D.E. Beaton, BScOT, PhD, Department of Occupational Sciences and Occupational Therapy, Institute for Health Policy Management and Evaluation, University of Toronto; F. Gandjbakhch, MD; Laure Gossec, MD, PhD, UPMC, GRC-UPMC 08 (EEMOIS); AP-HP Pitié Salpêtrière Hospital, Department of Rheumatology; F. Guillemin, MD, PhD, Université de Lorraine, Université Paris Descartes, EA 4360 APEMAC, Nancy and Inserm CIC-EC, CHU de Nancy; S. Hewlett, PhD, RN, Department of Nursing, University of the West of England; M. Kloppenburg, MD, PhD, Department of Rheumatology, Leiden University Medical Center; P.J. Mease, MD, Swedish Medical Center and University of Washington; I. Moller, MD, Instituto Poal; L.S. Simon, MD, SDG LLC; J.A. Singh, MD, MPH, Birmingham Veterans Affairs Medical Center and University of Alabama at Birmingham; V. Strand, MD, Division of Immunology/Rheumatology, Stanford University School of Medicine; R.J. Wakefield BM, MD, FRCP, Leeds Institute of Rheumatic and Musculoskeletal Medicine, University of Leeds, and NIHR, Leeds Musculoskeletal Biomedical Research Unit; G. Wells, Epidemiology and Community Medicine; P. Tugwell, MD, Department of Medicine, University of Ottawa; P.G. Conaghan, MB, BS, PhD, FRACP, FRCP, Leeds Institute of Rheumatic and Musculoskeletal Medicine, University of Leeds, and NIHR, Leeds Musculoskeletal Biomedical Research Unit. Address correspondence to Prof. D’Agostino, Rheumatology Department, APHP Ambroise Paré Hospital, 9 avenue Charles de Gaulle, 92100 Boulogne-Billancourt, France. E-mail: mariaantonietta.dagostino@apr.aphp.fr
Philip G. Conaghan
From Versailles-Saint Quentin En Yvelines University, Department of Rheumatology, Ambroise Paré Hospital, APHP, Boulogne-Billancourt, France; Departments of Epidemiology and Biostatistics, and Rheumatology, VU University Medical Center, Amsterdam, The Netherlands; University of Bristol, Academic Rheumatology Unit, Bristol Royal Infirmary, Bristol, UK; Department of Rheumatology, Leiden University Medical Center, Leiden, The Netherlands; Copenhagen Center for Arthritis Research, Center for Rheumatology and Spine Diseases, Copenhagen University Hospital Glostrup, Copenhagen, Denmark; Department of Internal Medicine 3 and Institute for Clinical Immunology, University of Erlangen-Nuremberg, Erlangen, Germany; Department of Clinical Immunology and Rheumatology, Academic Medical Center, University of Amsterdam and Atrium Medical Center, Amsterdam, The Netherlands; Department of Medicine, University of Alberta, Edmonton, Alberta, Canada; Department of Rheumatology, Hospital General Universitario Gregorio Marañón, Madrid, Spain; Paris-Descartes University, Medicine Faculty, APHP, Cochin Hospital, Rheumatology B, Paris, France; Rheumatology Unit, Sapienza Università di Roma, Rome, Italy; Division of Rheumatology, Johns Hopkins University, Baltimore, Maryland, USA; University of Melbourne, Medicine, Dentistry and Health Sciences, Melbourne, Australia; St. Michael’s Hospital, Mobility Program Clinical Research Unit; Institute for Work and Health; University of Toronto, Department of Health Policy, Management and Evaluation, Department of Rehabilitation Science and Department of Occupational Science and Occupational Therapy, Toronto, Ontario, Canada; Pierre et Marie Curie University (UPMC) — Paris, GRCUPMC 08 (EEMOIS); AP-HP Pitié Salpêtrière Hospital, Department of Rheumatology, Paris; Université de Lorraine, Université Paris Descartes, EA 4360 APEMAC, Nancy and Inserm CIC-EC, CHU de Nancy, Nancy, France; Department of Nursing, University of the West of England, Bristol, UK; Swedish Medical Center and University of Washington, Seattle, Washington, USA; Instituto Poal, Barcelona, Spain; SDG LLC, Cambridge, Massachusetts; Birmingham Veterans Affairs Medical Center and University of Alabama at Birmingham, Birmingham, Alabama; Division of Immunology/Rheumatology, Stanford University School of Medicine, Palo Alto, California, USA; Leeds Institute of Rheumatic and Musculoskeletal Medicine, University of Leeds, and UK National Institute for Health Research, Leeds Musculoskeletal Biomedical Research Unit, Leeds, UK; Department of Epidemiology and Community Medicine, and Department of Medicine, University of Ottawa, Ottawa, Ontario, Canada. M-A. D’Agostino, MD, PhD, Versailles-Saint Quentin En Yvelines University, Department of Rheumatology, Ambroise Paré Hospital, APHP; M. Boers, MD, PhD, Departments of Epidemiology and Biostatistics, and Rheumatology, VU University Medical Center; J.R. Kirwan, MD, University of Bristol, Academic Rheumatology Unit, Bristol Royal Infirmary; D.M. van der Heijde, MD, PhD, Department of Rheumatology, Leiden University Medical Center; M. Østergaard, MD, PhD, DMSc, Copenhagen Center for Arthritis Research, Center for Rheumatology and Spine Diseases, Copenhagen University Hospital Glostrup; G. Schett, MD, Department of Internal Medicine 3 and Institute for Clinical Immunology, University of Erlangen-Nuremberg; R.B. Landewé, MD, PhD, Department of Clinical Immunology and Rheumatology, Academic Medical Center, University of Amsterdam and Atrium Medical Center; W.P. Maksymowych, FRCPC, Department of Medicine, University of Alberta; E. Naredo, MD, Department of Rheumatology, Hospital General Universitario Gregorio Marañón; M. Dougados, MD, Paris-Descartes University, Medicine Faculty, APHP, Cochin Hospital, Rheumatology B; A. Iagnocco, MD, Rheumatology Unit, Sapienza Università di Roma; C.O. Bingham III, MD, Division of Rheumatology, Johns Hopkins University; P. Brooks, MD, FRACP, University of Melbourne, Medicine, Dentistry and Health Sciences; D.E. Beaton, BScOT, PhD, Department of Occupational Sciences and Occupational Therapy, Institute for Health Policy Management and Evaluation, University of Toronto; F. Gandjbakhch, MD; Laure Gossec, MD, PhD, UPMC, GRC-UPMC 08 (EEMOIS); AP-HP Pitié Salpêtrière Hospital, Department of Rheumatology; F. Guillemin, MD, PhD, Université de Lorraine, Université Paris Descartes, EA 4360 APEMAC, Nancy and Inserm CIC-EC, CHU de Nancy; S. Hewlett, PhD, RN, Department of Nursing, University of the West of England; M. Kloppenburg, MD, PhD, Department of Rheumatology, Leiden University Medical Center; P.J. Mease, MD, Swedish Medical Center and University of Washington; I. Moller, MD, Instituto Poal; L.S. Simon, MD, SDG LLC; J.A. Singh, MD, MPH, Birmingham Veterans Affairs Medical Center and University of Alabama at Birmingham; V. Strand, MD, Division of Immunology/Rheumatology, Stanford University School of Medicine; R.J. Wakefield BM, MD, FRCP, Leeds Institute of Rheumatic and Musculoskeletal Medicine, University of Leeds, and NIHR, Leeds Musculoskeletal Biomedical Research Unit; G. Wells, Epidemiology and Community Medicine; P. Tugwell, MD, Department of Medicine, University of Ottawa; P.G. Conaghan, MB, BS, PhD, FRACP, FRCP, Leeds Institute of Rheumatic and Musculoskeletal Medicine, University of Leeds, and NIHR, Leeds Musculoskeletal Biomedical Research Unit. Address correspondence to Prof. D’Agostino, Rheumatology Department, APHP Ambroise Paré Hospital, 9 avenue Charles de Gaulle, 92100 Boulogne-Billancourt, France. E-mail: mariaantonietta.dagostino@apr.aphp.fr
In this issue
The Journal of Rheumatology
Vol. 51, Issue 4
1 Apr 2024
Updating the OMERACT Filter: Implications for Imaging and Soluble Biomarkers
Maria-Antonietta D’Agostino, Maarten Boers, John Kirwan, Désirée van der Heijde, Mikkel Østergaard, Georg Schett, Robert B. Landewé, Walter P. Maksymowych, Esperanza Naredo, Maxime Dougados, Annamaria Iagnocco, Clifton O. Bingham , Peter M. Brooks, Dorcas E. Beaton, Frederique Gandjbakhch, Laure Gossec, Francis Guillemin, Sarah E. Hewlett, Margreet Kloppenburg, Lyn March, Philip J. Mease, Ingrid Moller, Lee S. Simon, Jasvinder A. Singh, Vibeke Strand, Richard J. Wakefield, George A. Wells, Peter Tugwell, Philip G. Conaghan
The Journal of Rheumatology Mar 2014, jrheum.131313; DOI: 10.3899/jrheum.131313
Updating the OMERACT Filter: Implications for Imaging and Soluble Biomarkers
Maria-Antonietta D’Agostino, Maarten Boers, John Kirwan, Désirée van der Heijde, Mikkel Østergaard, Georg Schett, Robert B. Landewé, Walter P. Maksymowych, Esperanza Naredo, Maxime Dougados, Annamaria Iagnocco, Clifton O. Bingham , Peter M. Brooks, Dorcas E. Beaton, Frederique Gandjbakhch, Laure Gossec, Francis Guillemin, Sarah E. Hewlett, Margreet Kloppenburg, Lyn March, Philip J. Mease, Ingrid Moller, Lee S. Simon, Jasvinder A. Singh, Vibeke Strand, Richard J. Wakefield, George A. Wells, Peter Tugwell, Philip G. Conaghan
The Journal of Rheumatology Mar 2014, jrheum.131313; DOI: 10.3899/jrheum.131313